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Abstract
Importance: A Mediterranean-style diet has been shown to be effective in
improving a variety of disease outcomes, including metabolic risk factors. Such
dietary patterns are complex and, thus it is currently unclear as to which
components and intervention characteristics are more greatly associated with
reducing metabolic syndrome risk.
Objective: To obtain overall effect sizes for the metabolic risk factors (waist
circumference, HDL cholesterol, triglycerides, fasting blood glucose, systolic
blood pressure, and diastolic blood pressure) and explain the variability across
the current literature based on study design, sample, and diet characteristics.
Data Sources: Six electronic databases (PubMed, EMBASE, Web of Science,
CINAHL, CAB Direct, and Agricola) were searched from inception until August 4,
2014 using a comprehensive Boolean search strategy.
Study Selection: Studies were included if pre- and post- intervention
measurements of waist circumference were reported and the traditional
Mediterranean-style diet was used as a dietary intervention. Data from 32 studies
(N = 3,550) were included.
Data Extraction and Synthesis: Independent researchers identified studies that
met the inclusion criteria and coded methodological, participant, and intervention
characteristics.
Main Outcomes and Measures: Weighted mean effect size under randomeffects assumptions were obtained and modeled after pooling the individual
standardized mean differences for each study on the six metabolic risk factors.
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Results: There were significant beneficial effects in favor of the traditional
Mediterranean-style diet for waist circumference, triglycerides, fasting blood
glucose, systolic blood pressure, and diastolic blood pressure (d+=-0.58, 95% CI
-0.81 to -0.35; d+=-0.33, 95% CI -0.69 to -0.19; d+=-0.51, 95% CI -0.80 to -0.22;
d+=-0.74, 95%CI -1.03 to -0.46; d+=-0.92, 95% CI -1.41 to -0.43, respectively).
The Mediterranean-style diet was significantly beneficial when, in general the
intervention period was longer in duration, the study was conducted in Europe,
the study used a behavioral technique, and the study was conducted primarily
using small groups.
Conclusions and Relevance: The traditional Mediterranean-style diet had a
significant beneficial effect on five of the six metabolic risk factors. This dietary
pattern appears to be most successful in reducing metabolic risk when it is
recommended for longer periods of time and is implemented using social
support.
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Introduction
Metabolic syndrome is defined as a group of interrelated risk factors of
metabolic origin that appear to directly promote the development of
cardiovascular disease (CVD)1. These metabolic risk factors are also associated
with the development of type 2 diabetes mellitus1. Underlying risk factors for
metabolic syndrome include abdominal obesity, insulin resistance, physical
inactivity, aging, hormonal imbalance, and genetic or ethnic predisposition1.
Currently, lifestyle therapies such as diet modification and physical activity are
first-line interventions to treat the metabolic risk factors1.

The traditional

Mediterranean-style diet (MedSD) is well-known for its cardio-protective benefits2
and should be considered for prevention and treatment of metabolic syndrome.
The National Cholesterol Education Program’s Adult Treatment Panel III
report (NCEP ATPIII)3 identified six components of metabolic syndrome that are
related to CVD: 1) abdominal obesity, 2) atherogenic dyslipidemia, 3) elevated
blood pressure, 4) insulin resistance, 5) proinflammatory state, and 6)
protrhombotic state3. According to the ATP III criteria, a diagnosis of metabolic
syndrome can be made when three out of five of the following characteristics are
present: 1) abdominal obesity characterized by waist circumference >102 cm for
men and >88 cm for women, 2) triglycerides ≥150mg/dL, 3) HDL cholesterol <40
mg/dL for men and <50 mg/dL for women, 4) blood pressure ≥130/≥85 mmHg,
and 5) fasting glucose ≥110 mg/dL3.

Metabolic syndrome is a major health

concern in the United States with increasing prevalence. Findings from the Third
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National Health and Nutrition Examination Survey (NHANES) suggest that
according to the ATP III criteria approximately 34% of adults in the United States
have metabolic syndrome4. Males and females 40-59 years of age were about
three times more likely as those 20-39 years of age to meet the criteria for
metabolic syndrome4. Males 60 years of age and older were four times as likely
and females 60 years of age and older were more than six times as likely as the
youngest age group (20-39 years of age) to meet the criteria for metabolic
syndrome4.

With the increasing prevalence of metabolic syndrome, diet

modification, particularly adherence to the traditional MedSD, should be
considered as a lifestyle change.
The MedSD refers to the dietary habits traditionally followed by people in
the countries bordering the Mediterranean Sea2. The traditional MedSD puts
emphasis on an abundance of food from plant sources, a variety of minimally
processed and locally grown foods, and olive oil as the principal source of fat5.
This dietary pattern also includes daily consumption of low to moderate amounts
of cheese and yogurt (low-fat and non-fat versions may be preferable), twice
weekly consumption of fish and poultry, consumption of up to seven eggs per
week, fresh fruit as dessert, red meat consumption limited to a few times a
month, moderate consumption of wine (1 glass/day for women and 1-2
glasses/day for men) and regular physical activity at a level which promotes
healthy weight and well-being5.
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The beneficial role of the MedSD with regard to overall mortality and other
chronic diseases is well-established.

A 2010 meta-analysis of prospective

studies found that adherence to the Mediterranean diet suggests significant
protection against major chronic degenerative diseases, a significant reduction in
death from any cause, a reduction in the incidence of cardio-and cerebrovascular diseases, reduction in the incidence of neoplastic diseases, and
reduction of the incidence of neurodegenerative diseases2.

In addition, a

secondary analysis of the PREDIMED6 trial concluded that an energyunrestricted Mediterranean diet may be useful in reducing the risks of central
obesity and hyperglycemia in people at high risk of CVD7. However, there is
limited evidence on the effect of a traditional MedSD on metabolic risk factors.
To our knowledge, only one meta-analysis has evaluated literature on the
effects of a Mediterranean diet on metabolic syndrome to date8. This metaanalysis included 35 clinical trials, 2 prospective studies, and 13 cross-sectional
studies with a total of 534,906 participants and found an overall beneficial effect
of the Mediterranean diet on reducing metabolic syndrome and its components in
adults88. Further, the Scientific Report of the 2015 Dietary Guidelines Advisory
Council9 found dietary characteristics similar to that of a MedSD, including higher
intake of vegetables, fruits, seafood, legumes, and nuts; moderate intake of
alcohol (among adults); lower consumption of red and processed meat, and low
intake of sugar-sweetened foods and drinks9, to have a positive effect on
metabolic syndrome risk factors (i.e., blood pressure and lipid profiles). Taken
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together, the findings from the meta-analysis by Kastorini et al.8 noted above and
the 2015 Dietary Guidelines Advisory Council9 clearly support the positive effects
of the MedSD on metabolic risk factors. However, it is currently unclear which
specific characteristics of these MedSD interventions greatly contribute to
significant beneficial effects on the metabolic risk factors such as specific
population, location, length of adherence to the MedSD and specific dietary
components. Analyzing particular moderators within the current evidence can
allow for the development of population specific guidelines to enhance the
beneficial effects of the MedSD as well as increase adherence to this dietary
pattern.
As mentioned above, CVD risk factors and metabolic syndrome are
interrelated such that the diagnostic criteria defining metabolic syndrome
encompasses a cluster of health outcomes related to CVD risk.

Several

systematic reviews and meta-analyses published within the last 10 years that
have focused on the MedSD and CVD risk outcomes have reported an overall
beneficial effect of the MedSD in reducing CVD risk factors10. Before evidencedbased guidelines for CVD risk reduction can be put into practice, these metaanalyses should undergo a formal evaluation of quality. To address this issue,
we recently conducted a review10 of methodological quality of systematic reviews
and meta-analyses on the MedSD and CVD risk outcomes using an established
methodological quality scale (Assessment of Multiple Systematic Reviews11). On
average, reviews achieved a low quality score (Mean = 7.9±5.10) relative to the
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maximum AMSTARMD score of 2010. Four reviews satisfied at least 80% of the
items possible, suggesting relatively high quality, 3 satisfied at least 45% of the
items, suggesting moderate quality, and the other 13 satisfied less than 45% of
the items, suggesting low quality10.

The data from this review suggest that

current meta-analyses evaluating the effects of the MedSD on CVD risk do not
fully comply with contemporary methodological quality standards. This review
provides evidence to support the need for high quality systematic reviews and
meta-analyses on the MedSD and various health outcomes that comply with
current methodological quality standards.
Given the increasing prevalence of metabolic syndrome, the popularity
and relevance of the MedSD, and the reported quality issues of current metaanalyses that have focused on the MedSD, we were interested in evaluating the
effects of the traditional MedSD on the following metabolic risk factors: 1) waist
circumference, 2) HDL cholesterol, 3) triglycerides, 4) systolic blood pressure, 5)
diastolic blood pressure, and 6) fasting blood glucose. The purpose of this work
was to conduct a high-quality meta-analysis to evaluate the relationship between
the traditional MedSD and metabolic risk factors. This study had three specific
aims: 1) to obtain overall effect sizes for each outcome of interest (waist
circumference, HDL cholesterol, triglycerides, systolic blood pressure, diastolic
blood

pressure,

and

fasting

blood

glucose),

2)

to

evaluate

the

variability/consistency across the current literature on this topic, and 3) to explain
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the variability across the current literature on this topic using moderators based
on study, sample, and diet characteristics.
Our primary hypothesis is that effects for each outcome will favor the
traditional MedSD against baseline (standardized mean difference, d≠0) with a
null hypothesis that the traditional MedSD will have no impact on metabolic risk
factors (d=0). Our second hypothesis is that the studies will show large and
significant variability based on the Q statistic and the I2 index.

Lastly, we

hypothesized that the variability will be explained using moderators based on
sample, diet and study characteristics.
Methods
Literature Search
The data sources were obtained following the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses: The PRISMA Statement12
guidelines.

Original research studies that were published regardless of

publication type until August 4, 2014 were included.
restricted.

Language was not

Six computer databases were searched: PubMed, EMBASE (via

Scopus), Web of Science, CINAHL, Agricola, and CAB Direct. A comprehensive
literature search was conducted with the assistance of the University of
Connecticut Health Sciences Librarian (JL) using combinations of Medical
Subject Headings and other key words related to the aim of the study. Examples
of the key words include: “Mediterranean Diet”, “Mediterranean Style Diet”,
adiposity,

“metabolic

syndrome”,

overweight,

BMI,

“body

mas”,

“waist
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circumference”, obese, obesity, “abdominal fat”, and “weight loss”.

The

comprehensive search that was conducted for each database can be found in
Appendix 1.

In addition to the electronic database search, all studies from

Kastorini, et al.8 were screened and four studies overlap in both meta-analyses.
The original search focused on obesity outcomes such as weight, BMI, and waist
circumference. With the current focus on metabolic risk factors, studies must
report pre-and post-intervention data on waist circumference in order to be
included in the analysis.

Manuscripts that met the following criteria were

included: studies that had pre- and post-intervention measurements for at least
waist circumference (any other metabolic risk factors were additional) and
studies that focused on the Mediterranean diet as a whole dietary pattern.
Studies that did not have pre- and post- intervention data on waist circumference,
those that focused on particular components of the Mediterranean diet, such as
only olive oil, those that included exercise in the intervention, and those that did
not report the information in a way that would allow effect sizes to be calculated
using the published information were excluded. The relevance of studies was
assessed by two independent researchers (MG and JS) with a hierarchical
approach on the basis of title, abstract, and full manuscript. The original search
resulted in 1,269 abstracts with relevant key words. After screening and handsearching articles, 32 articles (41 total comparisons) that used the traditional
MedSD were included in analysis. Refer to Figure 1 for the PRISMA figure of
included and excluded articles.

Table 1 provides a description of included
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studies. The screening form used by both coders can be found in Appendix 2.
A list of excluded articles is available upon request.
Data Extraction
A comprehensive and detailed coding form and manual was created by a
team of researchers comprised of registered dietitians, a biostatistician, and a
physician. The coding form includes approximately 330 variables for each study.
Various characteristics were extracted from each study: 1) sample characteristics
such as ethnicity, number and proportion of females, location of sample, and
recruitment details, 2) intervention characteristics such as length of intervention,
diet type, distribution of macronutrients, calorie intake, and participation in dietary
counseling, and 3) study design characteristics such as number of interventions,
type of control group, experimental conditions, and setting. The coding form was
pilot-tested by two independent researchers (MG and JS) and was reviewed by
additional experts (JB, JK, AK, TBHM) before being finalized.

The coding form

can be found in Appendix 3. The coding manual is available upon request. All
32 studies were independently reviewed and coded by two researchers (MG and
JS) and disagreements were solved by a third-party expert (TBHM).
Risk of Bias
The Cochrane Collaboration’s tool for assessing risk of bias was used to
assess risk of bias within individual studies13. Raters score items with either a
minus sign (“-“) indicating high risk of bias; a plus sign (“+”) indicating moderate
risk of bias; or a double plus sign (“++”) indicating low risk of bias for that
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parameter.

In accordance with these guidelines, we report descriptions of

internal and external validity summary ratings categorically, converting these to
numerical scores as necessary for the purpose of meta-analytic moderator
analysis.
Methodological quality (MQ) rankings have been identified as an underanalyzed element of the data reported in meta-analyses14. In this meta-analysis,
MQ ratings based on the Cochrane risk of bias scale were entered as one or
more possible moderators into the mixed-effects metaregression models.
Statistical Analysis
All descriptive statistics for the included articles were calculated using
SAS Version 9.415. All code for this analysis can be found in Appendix 4. Interrater reliability was calculated for all continuous and categorical variables using
IBM SPSS Statistics Version 2216.
calculate

categorical

agreement17

The Kappa (κ) coefficient was used to
(kappa=0.94,

96.9%

agreement)

and

Pearson’s correlation coefficient was used to calculate continuous agreement18
(r=1). We tested for asymmetries by using the Begg19, Egger20, and trim-and-fill21
statistical tests as well as the funnel plot

22

graphical technique. Publication bias

and the remaining statistical tests were calculated using R version 3.1.223
“metafor” package24. All code for this analysis can be found in Appendix 5.
Effect sizes (ESs) were calculated for each outcome by calculating the
standardized mean change25 for each sample. The standardized mean change,
d, is the difference between the post-test and pre-test means for one sample,
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divided by the pre-test standard deviation25. The standardized mean change
allows results from several kinds of designs to be compared or combined directly,
eliminating the need to omit studies because of design differences25,26 (i.e.,
between versus within-in group).

The effect size index, d, follows a normal

distribution with a range from negative infinity to positive infinity with zero as the
null value. Following Cohen’s classification the magnitude of the standardized d
value can be interpreted as 0.25, 0.5, and 0.8 for small, median, and large effects
on the outcomes of interest17. However, ESs should be interpreted based on
their clinical impact depending on the specific outcome and area of research.
ESs were calculated using an effect size coding calculator created by HuedoMedina, et al.27. This calculator uses a factor that controls for small sample
size28.
The data extracted to obtain the individual ESs could be means and
standard deviations, F-ANOVA, t-test, or mean and standard deviation change.
To uphold the assumption of independence, each outcome was analyzed
independently when multiple outcomes were reported from the same study.
Twenty four studies report at least three outcomes with the most common
outcomes being waist circumference, HDL cholesterol, and triglycerides; fifteen
studies reported all six outcomes of interest. A multivariate approach for multiple
subsamples per study was not followed because no more than five comparisons
were available per study. Multiple ESs were obtained from the same study when
data was reported separately by participant and diet characteristics29,30. Only two
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studies had subsamples based on gender31,32, three studies had multiple
subsamples for participant characteristics33,34,35, and one study had subsamples
based on different distributions of macronutrients throughout the day36.
Weighted mean effect size by the inverse of the variance of each study
was calculated across all studies under random- and fixed-effects assumptions37.
The random effects model assumes that the data is coming from different
populations and accounts for within and between-study variance37. The fixed
effects model assumes that all effect sizes are from the same population and
accounts for only within study variance37. To test for heterogeneity, Cochran’s Q
and I2 were calculated. Q tests for significance of heterogeneity38 whereas I2
calculates the magnitude of heterogeneity with a range from 0%-100%39. To
evaluate the sources of heterogeneity of the ESs, moderator analysis using
weighted mixed-effects models with maximum likelihood estimation of the
random-effects weights was performed testing each variable for study,
intervention, and participant characteristics independently. Moderator analysis
was conducted by using the “mods” command in R.

The moving constant

technique40 was used to produce estimates of the ES (d+) at meaningful levels of
the moderators and their CIs at different levels of interest. This technique was
used to demonstrate results at the maximum and minimum values of significant
moderators. Two-sided statistical significance was p<0.05. Finally, clinical units
of measures were included by transforming arithmetically the standardized ES to
its unstandardized version41.
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Results
Analysis of 32 reports shows that out of 3,550 participants, 74% were
female with a mean age of 47.19 (SD=11.29). A majority of the studies were
conducted in Europe (53.56%) and published in English (97.97%). The included
studies varied in design: 37.72% had a non-MedSD comparison group, 10.26%
of studies were crossover design, and 33.9% were pre-/post-test only design.
The mean publication year was 2010 (SD=2.64) with an 11 year range from
2003-2014. The mean intervention length was 32.4 (SD=45.34) weeks with a
range from four to 208 weeks. No significant asymmetries were found using any
of the statistical tests or the graphical funnel plot. A summary of the publication
bias results can be found in Table 2.
Effect Sizes
The traditional MedSD was found to have a significant beneficial effect on
five out of six outcomes of interest.

Overall ESs under random-effects

assumptions indicate that the traditional MedSD has a significant overall effect on
waist circumference, triglycerides, fasting blood glucose, systolic blood pressure,
and diastolic blood pressure (d+=-0.58, 95%CI -0.81 to -0.35; d+=-0.33, 95%CI 0.69 to -0.19; d+=-0.51, 95%CI -0.80 to -0.22; d+=-0.74, 95%CI -1.03 to -0.46;
d+=-0.92, 95%CI -1.41 to -0.43, respectively).

The null hypothesis regarding

significant effects on metabolic risk factors was rejected for a majority of the
outcomes of interest.

There was not enough evidence to reject the null

hypothesis for HDL cholesterol (d+=0.17, 95%CI -0.08 to 0.42). There is large
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heterogeneity between studies with I2 ranging from 93.01%-98.23%. There was
enough empirical evidence to reject the null hypothesis for variability between
studies. Refer to Table 3 for the overall effect sizes and homogeneity for each of
the metabolic risk factors. Please refer to Figures 2-7 for the forest plots for
each of the metabolic risk factors.

Moderator Analysis
Moderator analysis was conducted in order to use the descriptive
variables to account for some of the variability between studies. Studies included
in this meta-analysis varied in some characteristics in regard to study design,
population, and dietary intervention.

In regards to study characteristics,


marginally significant associations were found for study region (
=2.9%,

p=0.23; 
=16.69%, p=0.08;  =4.42%, p=0.28;  

= 3.5%, p=0.33 for

waist circumference, HDL cholesterol, triglycerides, and fasting blood glucose,
respectively). Studies conducted in Europe showed significant beneficial effects
from the traditional MedSD intervention on four of the metabolic risk factors (dwc=
-0.82, 95%CI: -1.12, -0.51; dHDL=0.55, 95%CI: 0.21, 0.89; dTG= -0.71, 95%CI: 1.08, -0.35; dFBG= -0.75, 95%CI: -1.15, -0.35 for waist circumference, HDL
cholesterol, triglycerides, and fasting blood glucose, respectively), whereas those
studies conducted in the United States did not result in significant effect sizes
(dwc= -0.33, 95%CI:-0.88, -0.21; dHDL=-0.10, 95%CI:-0.59, 0.39; dTG= -0.13,
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95%CI:-0.75, 0.48; dFBG=-0.18, 95%CI:-0.96, 0.60 for waist circumference, HDL
cholesterol, triglycerides, and fasting blood glucose, respectively).
Significant associations were found for study design for five of the six


metabolic risk factors (
= 25.19%, p=0.002; 
= 49.12%, p<0.0001;

 =33.71%, p=0.0008;  

= 32.81%, p=0.0015;   = 29.09%, p<0.001 for

waist circumference, HDL cholesterol, triglycerides, fasting blood glucose, and
systolic blood pressure, respectively). Studies using a comparison intervention
group design (i.e., a different type of diet) had more beneficial significant effect
sizes (dwc=-1.14, 95%CI:-1.51, -0.77; dHDL=0.79, 95%CI:0.46, 1.13; dTG=-0.99,
95%CI:-1.37, -0.06; dFBG= -1.13, 95%CI:-1.58, -0.67; dSBP=-1.36, 95%CI:-1.84, 0.88; dDBP=-1.32, 95%CI:-2.27, -0.36 for waist circumference, HDL cholesterol,
triglycerides, fasting blood glucose, systolic blood pressure, and diastolic blood
pressure, respectively) compared to those studies using a traditional pre-/postdesign or a crossover design (dwc= -0.34, 95%CI: -0.58, -0.09;

dSBP=-

0.51,95%CI:-0.79,-0.23; dDBP=-0.77, 95%CI:-1.34,-0.19 for waist circumference,
systolic blood pressure, and diastolic blood pressure, respectively).
Studies with a higher Impact per Publication (IPP) value showed more
significant beneficial effects for four out of six of the metabolic risk factors


(
=45.1%, p<0.0001; 
=37.03%, p=0.0015;  =23.74%, p=0.014;  

=

39.48%, p=0.0005 for waist circumference, HDL cholesterol, triglycerides, and
fasting blood glucose, respectively). A predictive model was performed in order
to determine the magnitude of effect for the minimum and maximum IPP score (0
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and 16.104). There were significant associations for IPP value for four outcomes
of interest (Bwc= -0.11, p<0.0001; BHDL=0.07, p=0.002; BTG=-0.06, p=0.01; BFBG=0.08, p=0.0005 for waist circumference, HDL cholesterol, triglycerides, fasting
blood glucose, respectively). In the predictive model, the maximum IPP score
resulted in more significant beneficial effect sizes than the minimum IPP score.
The length of the intervention (in weeks) significantly explains between
26.2% and 53.32% of the variability between studies for the following outcomes:
waist circumference, HDL cholesterol, triglycerides, fasting blood glucose and
systolic blood pressure.

The meta-regression plots for these analyses are

represented in Figures 8-13.

A predictive model was performed in order to

determine the magnitude of effect for the minimum and maximum lengths of
intervention (4 and 208 weeks). There was a significant association for length of
intervention for all six outcomes of interest (Bwc=-0.01, p<0.0001; BHDL=0.009,
p<0.0001; BTG=-0.008, p=0.006; BFBG=-0.009, p<0.001; BSBP=-0.007, p=0.005;
BDBP=-0.009, p=0.09 for waist circumference, HDL cholesterol, triglycerides,
fasting blood glucose, systolic blood pressure, and diastolic blood pressure,
respectively). The longer the length of the intervention, the more significant the
beneficial effect in favor of the traditional MedSD. These results are presented in
Table 4.
Additional significant or marginally significant intervention characteristics
include the use of a behavioral technique and dietary interventions conducted
primarily in small groups.

Whether or not a behavioral technique was used
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during the intervention (i.e., positive reinforcement or self-monitoring) explained
between 2.26% and 14.18% of the variability between studies. The use of a
behavioral technique resulted in marginally significant or significant beneficial
effects in all of the outcomes of interest (dwc= -0.73, 95%CI:-1.08, -0.38;
dHDL=0.50, 95%CI: 0.12, 0.89; dTG= -0.79, 95%CI:-1.21, -0.37; dFBG= -0.88,
95%CI: -1.34, -0.43; dSBP= -1.12, 95%CI: -1.56, -0.68; dDBP=-1.63, 95%CI: -2.35, 0.85 for waist circumference, HDL cholesterol, triglycerides, fasting blood
glucose, systolic blood pressure, and diastolic blood pressure, respectively)
compared to the effects when there was no behavioral technique used (dwc = 0.41, 95%CI:-0.71, -0.11; dHDL=-0.08, 95%CI:-0.42, 0.25; dTG= -0.27, 95%CI:0.59, 0.60; dFBG= -0.31, 95%CI: -0.69, 0.07; dSBP=-0.54, 95%CI:-0.92,-0.17;
dDBP=-0.53, 95%CI: -1.16, 0.11 for waist circumference, HDL cholesterol,
triglycerides, fasting blood glucose, systolic blood pressure, and diastolic blood
pressure, respectively).
The level of intervention or supervision during the study (i.e., primarily

one-on-one or small groups) resulted in significant associations (
=16.12%,

p=0.014;



=22.31%,

p=0.012;

 =25.64%,

p=0.006;



=19.01%,

p=0.004;   =30.73%, p=0.004) for waist circumference, HDL cholesterol,
triglycerides, fasting blood glucose, systolic blood pressure, and diastolic blood
pressure, respectively. Interventions consisting of small groups saw significant
beneficial effects for all six outcomes (dwc= -1.15, 95%CI: -1.61, -0.68; dHDL=0.64,
95%CI: 0.23, 1.05; dTG= -1.03, 95%CI:-1.46, -0.59; dFBG= -1.04, 95%CI: -1.52, -
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0.56; dSBP= -1.42, 95%CI: -1.91, -0.94; dDBP=-1.54, 95%CI: -2.43, -0.65 for waist
circumference, HDL cholesterol, triglycerides, fasting blood glucose, systolic
blood pressure, and diastolic blood pressure, respectively) compared to the
significant effects for two outcomes for those interventions that were primarily
one-on-one (dwc=-0.54, 95%CI:-0.88, -0.20; dSBP=-0.46, 95%CI:-0.83,-0.09 for
waist circumference and systolic blood pressure respectively).
Multiple variables were significant moderators only for diastolic blood
pressure (

=67.72%, p<0.0001, ; 

=72.57%, p<0.0001; 

=71.86%,

p<0.0001 for number of females, total sample size, and sample size of the
intervention group) resulting in significant associations (BDBP=-0.004, p<0.0001;
BDBP=-0.004, p<0.0001; BDBP=-0.005, p<0.0001, for number of females, total
sample size, and sample size of the intervention group, respectively).
In regards to specific components of the traditional MedSD interventions,
the following characteristics were not significant moderators for any of the
metabolic risk factors: carbohydrate intake ≥50% of calories, saturated fat intake
<10% of calories, total fat intake <30% of calories, and protein intake ≥15% of
calories. However, following these specific macronutrient proportions resulted in
more beneficial effects in favor of the traditional MedSD compared to
carbohydrate intake <50% of calories, saturated fat intake ≥10% of calories, total
fat intake ≥30% of calories, and protein intake <15% of calories. In addition to
the specific macronutrient proportions of the dietary intervention, whether or not
dietary compliance was assessed and whether or not the participants engaged in
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dietary counseling were also analyzed as moderators. There was no significant
association for either of these variables. There was a significant trend in favor of
the MedSD intervention in those interventions that assessed dietary compliance
as well as those that included dietary counseling as part of the intervention.
Participant characteristics, in particular the presence or absence of
certain disease states, were also analyzed as moderators.

These variables

included the presence or absence of cardiovascular disease, type II diabetes
mellitus, metabolic syndrome, and overweight/obesity. None of these variables
were significant moderators, however certain trends should be noted.
Participants with metabolic syndrome that followed the traditional MedSD had
more significant beneficial effects on five out of six of the metabolic risk factors
than those participants without metabolic syndrome. Conversely, in this model,
effects were more beneficial in favor of the MedSD in participants without
cardiovascular disease and without type II diabetes mellitus than those
participants with these diseases for all outcomes except HDL cholesterol.
Overweight/obese participants saw greater effects for waist circumference,
however, those without overweight/obesity saw greater effects for triglycerides.
All of the aforementioned effects were favorable, however no significant
moderation was found for these variables. Results from the moderator analysis
can be found in Table 4. Lists of non-significant moderators and moderators that
did not have enough information reported to be analyzed can be found in Table 5
and Table 6, respectively.

18

Risk of Bias
Risk of bias was unclear for random sequence generation, allocation,
blinding, incomplete outcome data, selective reporting, and other potential
sources of bias. Moderator analysis was not significant for any of the risk of bias
parameters.

Low risk of bias was found in 28.1% of articles for random

sequence generation and 9.3% of the articles had low risk of bias for allocation
concealment. 9.3% of the articles had low risk of bias and 6.3% of the articles
had high risk of bias for blinding of participants and personnel.

Blinding of

outcome assessment had 9.3% low risk of bias and 9.3% high risk of bias.
Imcomplete outcome data in the short-term and long-term both resulted in 6.3%
of articles with high risk of bias. No high or low risk of bias was reported for
selective reporting. 15.6% of articles had low risk of bias for other bias whereas
3.1% had high risk of bias for other bias. Refer to Figure 14 for a Risk of Bias
Summary.
Discussion
The present meta-analysis of 32 intervention trials found that the
traditional MedSD has significant beneficial effects on five out of six of the
metabolic risk factors: waist circumference, triglycerides, fasting blood glucose,
systolic blood pressure and diastolic blood pressure.

The significant

heterogeneity between studies was partly attributed to the location of the studies,
the length of the intervention, and the IPP value of the journal where the study
was published. To our knowledge, this is the first meta-analysis to evaluate the
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effects of the Mediterranean diet on metabolic syndrome, that meets 100% of the
AMSTAR criteria.
Our findings that a traditional MedSD is beneficial in reducing the risk of
CVD-associated metabolic parameters complements and extends previous work
in this area. Several recent systematic reviews and meta-analyses published on
the MedSD and CVD risk have reported similar positive effects on waist
circumference, triglycerides, systolic blood pressure, diastolic blood pressure,
and fasting blood glucose. These studies also found similar significant positive
associations in moderator analysis for studies conducted in Mediterranean
countries8,42, duration of study8, study design42, and study quality8,43. However,
we found that in general the meta-analyses and systematic reviews included in
this analysis possessed limitations in methodological quality, impacting the ability
to draw conclusions from their findings.
In our recent review of methologcial quality we used an established
methodological quality scale, AMSTAR, to evaluate the quality of 20 metaanalyses and systematic reviews on the MedSD and CVD risk. This review also
assessed the relationship between review quality and IPP value of the journal
where the article had been published. The PRISMA12 guidelines were used to
extract

scientific

literature

from

eight

comprehensive Boolean search strategy.

computer

datatbases

using

a

Databases were searched until

November 7, 2013 and 20 reports were coded and included in analysis. Included
reports were published between 2006 and 2013. Five of the reports were metaanalyses, 11 were systematic reviews, and four were both systematic reviews
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and meta-analyses10. Four of the included studies reviewed moderation patterns
and found that the MedSD effect was positive for different CVD risk outcomes
when, in general: 1) the effect was based on larger samples, 2) the samples
were more physically active, 3) the study was conducted in a Mediterranean
country, 4) the study period was longer in duration, and 5) study quality was
rated higher10.
We found that reviews published in higher IPP journals scored
significantly higher in total methodological quality10. Those reviews with higher
quliaty scores tended to report moderator analysis and homogeneity inference
test and did not have language restrictions in their search. There were three
positively significant associations between the IPP value and AMSTARMedSD
aspects: 1) use of duplicate study selection and data extraction, 2) using
appropriate statistics to combine findings, and 3) using and justifying an
appropriate effect size index

10

. Given these results, we felt it was imperative to

follow all current methodological quality standards while conducting our current
meta-analysis on the traditional MedSD and metabolic risk factors. As noted
above, for this current meta-analysis, we were successful in meeting 100% of the
AMSTAR criteria and in using moderator analysis to explain some of the
variability between studies.
To our knowledge, there has only been one previously published metaanalysis on the effects of the Mediterranean diet on metabolic syndrome. This
2011 meta-analysis by Kastorini, et al.8 included 35 clinical trials, 2 prospective
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studies, and 13 cross-sectional studies with a total of 534,906 participants. They
found that overall, adherence to the Mediterranean diet was aossociated with a
beneficial effect in regard to waist circumference, HDL cholesterol, triglycerides,
and fasting glucose levels; overall, adherence to a Mediterranean diet was not
associated with beneficial effect in regard to systolic and diastolic blood pressure
levels8. However, in the present meta-analysis, significant beneficial effects were
found for waist circumference, triglycerides, fasting blood glucose, systolic blood
pressure and diastolic blood pressure, but not HDL cholesterol.
Using sensitivity analysis, Kastorini, et al.8 found significant associations
for studies conducted in a Mediterranean country and those studies lasting
longer than three months in duration for the following outcomes: HDL cholesterol,
triglyercides, systolic blood pressure, diastolic blood pressure, glucose, and
HOMA-IR8. Significant asscoications were found for all of the above outcomes
as well as waist circumference for interventions with more than or equal to 66
participants8. Recommendation of physical activity was significantly associated
with HDL cholesterol, triglycerides, systolic blood pressure, diastolic blood
pressure, and HOMA-IR, whereas no recommendation of physical activity was
significantly associated with systolic blood pressure, diastolic blood pressure,
and glucose8. Lastly, studies of high quality were significantly associated with
greater effects on HDL cholesterol, triglycerides, systolic blood pressure, diastolic
blood pressure, and HOMA-IR8.

In the present meta-analysis, significant

beneficial associations were found for studies conducted in Europe, studies of
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longer duration, studies using a behavioral technique, studies with a comparison
intervention group, studies with a higher IPP value, and studies conducted
primarily in groups for most of the metabolic risk factors. Our current sample of
studies did not report enough baseline physical activity information to analyze
that variable as a moderator. Interventions that included exercise were excluded
from this meta-analysis as that was considered a “MedSD plus” intervention
because it was not looking solely at the effects of the dietary intervention. For
the Kastorini, et al.8 meta-analysis, the literature search was limited to those
manuscripts published in English and to three computer databases.

Small

literature searches of only a few key terms at a time were conducted rather than
one comprehensive literature search. Clinical trials with lack of randomization,
lack of a control diet group, comparison of the Mediterranean diet against the
Mediterranean diet plus an additional intervention, or intervention without
inclusion of all of the components of a Mediterranean diet were excluded from
analysis 8. For the present meta-analysis language was not restricted for the
literature search, a comprehensive literature search was performed using six
electronic databases, and studies without comparison groups or with a lack of
randomization were not excluded.

The present meta-analysis and the meta-

analysis by Kastorini, et al.8 greatly contribute to the scientific literature in support
of the traditional MedSD and can assist with the creation and implementation of
evidence-based dietary guidelines for those samples that would most benefit
from this dietary pattern using the moderator analysis that has been conducted.
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The Scientific Report of the 2015 Dietary Guidelines Advisory Council
analyzed the scientific evidence of three healthy dietary patterns, one of which is
the MedSD9. This report summarizes the information from large, high-quality
randomized control trials related to the effects of the MedSD on multiple health
outcomes such as blood pressure and blood lipids9.

The Dietary Guidelines

Advisory council found that there were common characteristics among dietary
patterns associated with positive health outcomes. Some of these characteristics
were similar to those of the traditional MedSD such as higher intake of
vegetables, fruits, seafood, legumes, and nuts; moderate intake of alcohol
(among adults); lower consumption of red and processed meat, and low intake of
sugar-sweetened foods and drinks9. This reports highlights the significance and
importance of current, high-quality research on the MedSD.
Practical Applications
The results of this meta-analysis provide researchers and health
professionals with several immediate applications.

The moderator analysis

conducted in this meta-analysis demonstrates the importance of intervention
trials reporting as much detailed information about participant and intervention
characteristics as possible. Having this information would make more moderator
analysis possible allowing for more specific dietary recommendations to be
created for any dietary pattern, but especially the traditional MedSD. This metaanalysis is influential in the fields of dietetics and nutrition as both assessment of
dietary compliance and the use of a behavioral technique were two moderators
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with positive trends in favor of the MedSD.

The significant association in

beneficial effects agrees with weight loss interventions conducted by GokeeLaRose, et al44. Registered dietitians should be a vital component of any dietary
intervention trial in order to enhance beneficial effects on the outcomes of
interest. More significantly beneficial effects were found in those studies that
primarily use a small group intervention compared to one-on-one interventions,
which supports previous findings in dietary intervention studies that use small
group interventions45. Most importantly, the results of this meta-analysis agree
with most of the current systematic reviews and meta-analyses on the
Mediterranean diet.
Study Limitation and Strengths
This meta-analysis has several limitations and stregnths. There is still
significant heterogeneity between the studies that is unexplained which is a
limitation for this study. Multiple variables did not have enough data reported to
test for moderation effects. The data reported in our sample of studies did not
allow us to control for different types and duration of exercise in which
participants may have been engaging. Our last limitation is possible ecological
fallacy, as we did not have the raw data from the included studies, we should be
cautious interpreting the group results as individual effects. There are multiple
strengths for this meta-analysis. We used a comprehensive literature search in
six electronic databases and an inclusive and comprehensive coding form and
manual was created and used for data extraction. We performed moderation
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analysis on all variables that reported enough data to do so. To our knowledge,
this is the first meta-analysis to find significant associations with the use of
behavioral techniques and small group interventions. Lastly, we were able to use
the moving constant technique and a predictive model to calculate the effect size
at significant values of each significant moderator and transform that effect size
into the clinical unit of measure.
Conclusion
The results of the present meta-analysis suggest that adherence to the
traditional MedSD can have significant beneficial effects on wasit circumference,
triglycerides, fasting blood glucose, systolic blood pressure and diastolic blood
pressure with a positive trend for HDL cholesterol.

In addition, the

Mediterranean-style diet was significantly beneficial for different metabolic risk
factors when, in general the intervention period was longer in duration, the study
was conducted in Europe, the study was published in a journal with higher
Impact per Publication value, the study included a comparison intervention, the
study used a behavioral technique, and the study was conducted primarily using
small groups. More high-quality intervention studies are needed to evaluate the
relationship between the traditional MedSD and metabolic risk factors in order to
provide more detailed information for moderator analysis. This high quality metaanalysis on the effect of the traditional MedSD on metabolic risk factors
significantly contributes to the current body of scientific literature in favor of
MedSD.
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Figure 1. PRISMA Figure Outlining the Process of Study Identification,
Screening, Eligibility, and Inclusion
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Table 1. Description of Included Studies
Study

Country

N

%F

Age

Diseases

Recruitment

Dietary
Assessment

Type of
Diet

Duration
(weeks)

Control

Outcome

Aizawa, et
46
al. (2009)

Canada

63

51%

53.9

PDM

Physicia
n referral

Group,
unsupervised

MD

24

No
carotid
artery
stiffness

Carotid
artery
stiffness

Bedard, et
47
al. (2012)

Canada

67

NR

39

Ob (57%)

NR

Individual,
supervised

MD

8

Non-Ob

CVDRF

Bekkouche,
et al. (2014)

Algeria

86

NR

52

MS (67%)

Hospital

Individual,
unsupervised

MD

12

No MS,
healthy

IR, OS,
Inflam.

Netherlands

60

NR

52.5

Ob
(100%)

NR

Individual,
unsupervised

MD

10

High SFA
diet; High
MUFA
diet

Serum
lipids, IS

Calatayud, et
50
al. (2011)

Spain

98

56%

8.6

Ob (52%)

NR

NR

MD

52

None

WT loss

Connolly, et
51
al. (2011)

Great
Britain

206

42%

60.4

CVD or
CVDRF
(100%)

Hospital,
physician
referral

Individual,
unsupervised

MD

16

None

CVDRF

Corbalan, et
52
al. (2009)

Spain

140
6

82%

39

Ob
(100%)

Clinic
referral

Individual,
unsupervised

HMD

34

None

WT

Esposito, et
53
al. (2006)

Italy

65

0%

43.9

MS, ED
(100%)

Researc
h
database

Individual,
unsupervised

MD

24

Regular
diet

IIEF score

PHTN

48

Bos, et al.
49
(2010)

35

Esposito, et
54
al. (2007)

Italy

59

100
%

41.9

MS, FSD
(100%)

Researc
h
Databas
e

Individual,
unsupervised

MD

24

Regular
Diet

FSFI
score

Esposito, et
55
al. (2004)

Italy

180

45%

43.9

MS
(100%)

Clinic

Group,
unsupervised

MD

104

Regular
Diet

Endo func,
Vas Infl

Esposito, et
56
al. (2009)

Italy

215

51%

52.2

NIDDM
(100%)

Clinic

Group,
unsupervised

HMD

208

LF Diet

Glycemic
control

Goulet, et al.
57
(2003)

Canada

77

100
%

47

None,
healthy

Newspap
er ad.

Individual,
unsupervised

MD

12

None

Serum
lipid, WT

Goulet, et al.
58
(2007)

Canada

77

100
%

46.7

None,
healthy

Newspap
er ad.

Individual,
unsupervised

MD

24

None

WT

Jones, et al.
59
(2011)

United
States

89

100
%

47.5

MS
(100%)

NR

Individual,
unsupervised

LGMD-MF

12

LGMD,
no MF

MS RF

Kolomvotsou
, et al.
60
(2013)

Greece

90

48%

50.4

Ob
(100%)

Hospital

Individual,
unsupervised

Greek MD

8

Regular
diet

AO intake,
plasma
AO
capacity

LandaetaDiaz, et al.
61
(2013)

Spain

45

67%

58

Ob, MS
(100%)

Hospital

Individual,
unsupervised

HMD with
exercise

12

HMD
without
exercise

HRQoL

Leighton, et
62
al. (2009)

Chile

145

0%

39

MS (24%)

Maestran
za Diesel

Group,
supervised

MD

52

None

MS RF

Lerman, et
63
al. (2010)

United
States

24

83%

54.4

MS and
high LDLC (100%)

Previous
study by
Lerman

NR

LGMD-MF

12

LGMD,
no MF

Plasma
lipids

36

Lindeberg, et
64
al. (2007)

Sweden

29

0%

61

IHD, IGT,
NIDDM

Hospital

Individual,
unsupervised

MD

12

Paleolithi
c Diet

WT,
serum
glucose

Spain

116

100
%

56.4

IR (100%)

Hospital

Group,
unsupervised

MD, soy
suppleme
nt

104

MD, no
supp

IR

Lombardo, et
66
al. (2014)

Italy

42

100
%

46.3

Ob
(100%)

Hospital

Individual,
unsupervised

HMD

12

HMD

WT

Papandreou,
et al. (2012

Greece

40

NR

41.5

Ob, OSAS
(100%)

Universit
y
Medical
School

Group,
unsupervised

HMD

26

Prudent
Diet

OSAS

Papandreou,
et al.
68
(2012)

Greece

21

NR

41.5

Ob, OSAS
(100%)

Universit
y
Medical
School

Group,
unsupervised

HMD

26

Prudent
Diet

TBARS

Rallidis, et
69
al. (2009)

Greece

82

48%

50.4

Ob
(100%)

Hospital

Individual,
unsupervised

Greek MD

8

Regular
Diet

Endo func

Richard, et
70
al. (2011)

Canada

26

0%

49.4

MS
(100%)

NR

Individual,
unsupervised

MD

35

Western
Diet

CVDRF

United
States

126

68%

51

MS
(100%)

Physicia
n referral

Individual,
unsupervised

MD

12

None

WT, BP,
TG, serum
glucose

Ryan, et al.
72
(2013)

Australia

12

50%

55

NAFLD
(100%)

Hospital

Individual,
unsupervised

MD

6

LF diet

WT, IS

SanchezBenito, et al.

Spain

158

87%

48

OverWT
(100%)

Pharmac
y office

Individual,
unsupervised

MD

26

None

BMI, BP,
cholesterol

Llaneza, et
65
al. (2010)

67

Rubenfire, et
71
al. (2011)

37

(2012)

73

StendallHollis, et al.
74
(2013)

United
States

129

100
%

29.7

OverWT
(100%)

Magazin
e,
hospital,
Craigslist

Individual,
unsupervised

MD

16

MyPyram
id for
P&B

WT, Inflam
Bio

Timar, et al.
75
(2013)

Romania

223

50%

55

NIDDM
(100%)

Diabetes
Center

Group,
unsupervised

HMD

52

Diabetic
Diet

Glycemic
control,
CVDRF

Van Velden,
et al.
76
(2007)

South
Africa

12

25%

46

MS
(100%)

NR

Group,
unsupervised

MD with
red wine

8

MD
without
red wine

CVDRF

Wardle, et al.
77
(2000)

England

176

78%

53

Hyperchol
esterolemi
a (100%)

Hospital

Group,
unsupervised

MD

12

LF Diet,
Regular
Diet

Serum
cholesterol

Note. N, number of participants at baseline; F, females; NR, not reported; OWT, Overweight; Ob, Obesity; MD, Mediterranean
Diet; PDM, Pre-diabetes mellitus; PHTN, Pre-hypertension; HMD, Hypocaloric Mediterranean diet; CVDRF, Cardiovascular
Disease risk factors; MS, Metabolic Syndrome; Endo dys, endothelial dysfuction;, OS, oxidative stress; NIDDM, Non-insulin
Dependent Diabetes; FFMD, Fast food Mediterranean Diet; FF Cons, Fast food consumption; IR, insulin resistance; Inflam,
Inflammation; SFA, saturated fatty acid; IS, Insulin Sensitivity; CHD, Coronary Heart Disease; ED, Erectile Dysfunction; IIEF,
International Index of Erectile Function; FSD, Female Sexual Dysfunction; FSFI, Female Sexual Function Index; Endo Func.,
endothelial function; Vas Infl, vascular inflammation; MDN, Mediterranean Diet with nuts; MDO, Mediterranean Diet with olive oil;
EPC, endothelial progenitor cell; OC, serum osteocalcin; P1NP, procollagen type 1 N-terminal propeptide; LGMD-MF, LowGlycemic Mediterranean Diet with Medical Food; MS RF, Metabolic Syndrome Risk Factors; AO, antioxidant; HRQoL, Healthrelated quality of life; WC, waist circumference; IHD, ischaemic heart disease; IGT, impaired glucose tolerance; KEMEPHY,
Ketogenic Mediterranean Diet with phytoextracts; OSAS, Obstructive Sleep Apnea Syndrome; TBARS, thiobarbituric acid reacting
substances; TAC, total antioxidant capacity; HMDC, Hypocaloric Mediterranean Diet High Cereal; HMDV, Hypocaloric
Mediterranean Diet High Vegetable; BP, blood pressure; TG, serum triglycerides; Inflam Bio, inflammatory biomarkers;
MyPyramid for P&B, USDA MyPyramid Diet for Pregnant and Breastfeeding Women; BLS, Bright Liver Score; FVII, activated
factor VII; HLF Diet, Hypocaloric Low Fat Diet; MI, Myocardial Infarction
Note on Dietary Assessment column:

38

•
•
•
•

Individual: A dietitian performed a dietary assessment, providing individualized needs for caloric intake and
recommendations, for each participant.
Group: The study provided general dietary recommendations for the participants, such as a range of servings of certain
food groups, calories based on gender, as opposed to tailoring diets to individual needs based on weight and height.
Supervised: Participants consumed foods in a supervised setting, where the researchers had control over participant food
choices and quantity of food served.
Unsupervised: Participants food consumption was unsupervised by researchers, such as eating at home.
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Table 2. Publication Bias

Publication Bias
Egger'
Outcome

s

Begg's
p=0.64

WC

5

HDL

5

TG

2

FBG

9

p=0.001
p=0.96
p=0.56
p=0.21
p=0.125
p=0.79
p=0.016
p=0.34

SBP

p=0.027

p=0.60
DBP

3

p=0.032

Note: WC, waist circumference; HDL, HDL cholesterol; TG, triglycerides, FBG,
fasting blood glucose; SBP, systolic blood pressure; DBP, diastolic blood
pressure
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Table 3. Summary of Results, Overall Effect Sizes and Homogeneity

d+ (95% CI)
Outcome

WC

HDL

TG

FBG

SBP

DBP

k

45

40

38

33

30

30

Homogeneity of d’s

Fixed-Effects

Random-Effects

-0.41

-0.54

(-0.45 to -0.38)*

(-0.75 to -0.33)*

0.15

0.15

(0.09 to 0.19)*

(-0.02 to 0.32)

-0.27

-0.34

(-0.31 to -0.22)*

(-0.51 to -0.16)*

-0.36

-0.42

(-0.41 to -0.32)*

(-0.64 to -0.19)*

-0.61

-0.62

(-0.65 to -0.57)*

(-0.89 to -0.35)*

-0.68

-0.78

(-0.73 to -0.63)*

(-1.22 to -0.34)*

Q

I2 (%)

p-value

425.29

96.37

<0.0001

304.48

91.1

<0.0001

251.41

91.49

<0.0001

292.85

94.67

<0.0001

600.44

97.07

<0.0001

2633.41

98.51

<0.0001

Note: WC, waist circumference; HDL, HDL cholesterol; TG, triglycerides, FBG,
fasting blood glucose; SBP, systolic blood pressure; DBP, diastolic blood
pressure; * indicates a significant effect; k represents the number of interventions
for each outcome included in the anlaysis; Q represents Cochran’s Q indicating
significance of heterogeneity; I2 represents the magnitude of heterogeneity; pvalue represents the significance of heterogeneity.
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Table 4. Significant Moderator Analysis Results
Significant Moderator Analysis Results
Variable
Study Characteristics
Region

Outcome

WC

Category

Europe
US

HDL

Europe
US

TG

Europe
US

FBG

Europe
US

SBP

Europe
US

DBP

Europe
US

k

23
7
13
6
12
4
12
3
13
4
13
4

d+ (95% CI)
-0.82
(-1.12 to -0.51)
-0.33
(-0.59 to 0.39)
0.551
(0.21 to 0.89)
-0.01
(-0.59 to 0.39)
-0.71
(-1.08 to -0.35)
-0.13
(-0.75 to 0.48)
-0.75
(-1.15 to -0.35)
-0.181
(-0.96 to 0.60)
-0.97
(-1.54 to 0.53)
-0.47
(-1.38 to 0.43)
-1.27
(-2.56 to 0.90)
-0.44
(-1.95 to 1.07)

R2

p-value

Clinical Unit of
Measure

2.90%

0.23

-8.32 cm

2.90%

0.23

-3.41 cm

16.69%

0.08

1.65 mmol/L

16.69%

0.08

-0.31 mmol/L

4.42%

0.28

-24.89 mmol/L

4.42%

0.28

-4.69 mmol/L

3.50%

0.33

-0.23 mmol/L

3.50%

0.33

-0.06 mmol/L

0.00%

0.68

-3.17 mmol/L

0.00%

0.68

-1.54 mmol/L

0.00%

0.79

-2.97 mmol/L

0.00%

0.79

-1.03 mmol/L
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Study Design

WC

HDL

TG

FBG

SBP

DBP

Impact per Publication Metric

WC

HDL

MedSD vs. Other
Diet
Pre/Post or
Crossover
MedSD vs. Other
Diet
Pre/Post or
Crossover
MedSD vs. Other
Diet
Pre/Post or
Crossover
MedSD vs. Other
Diet
Pre/Post or
Crossover
MedSD vs. Other
Diet
Pre/Post or
Crossover
MedSD vs. Other
Diet
Pre/Post or
Crossover

13
27
9
19
8
18
7
17
7
19
7
19

0 (minimum)

39

16.104 (maximum)

39

0 (minimum)
16.104 (maximum)

27
27

-1.14
(-1.51 to -0.77)
-0.34
(-0.58 to -0.09)
0.79
(0.46 to 1.13)
-0.12
(-0.35 to 0.102)
-0.99
(-1.37 to -0.60)
-0.20
(-0.45 to 0.05)
-1.13
(-1.58 to -0.67)
-0.26
(-0.55 to 0.03)
-1.36
(-1.84 to -0.88)
-0.51
(-0.79 to -0.23)
-1.32
(-2.27 to -0.36)
-0.77
(-1.34 to -0.19)
-0.18
(-0.42 to 0.06)
-1.92
(-2.49 to -1.36)
-0.08
(-0.35 to 0.18)
0.96

25.19%

0.001

-11.63 cm

25.19%

0.001

-3.47 cm

49.12% <0.0001

2.37 mmol/L

49.12% <0.0001

-0.36 mmol/L

33.71%

0.0008

-34.65 mmol/L

33.71%

0.0008

-7.11 mmol/L

32.81%

0.002

-0.41 mmol/L

32.81%

0.002

-0.08 mmol/L

29.09%

0.003

-4.45 mmHg

29.09%

0.003

-1.67 mmHg

0.00%

0.34

-3.09 mmHg

0.00%

0.34

-1.8 mmHg

45.10% <0.0001

-1.84 cm

45.10% <0.0001

-19.58 cm

37.03%
37.03%

0.002
0.002

-0.24mmol/L
-2.88 mmol/L
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TG

FBG

SBP

DBP

0 (minimum)

25

16.104 (maximum)

25

0 (minimum)

23

16.104 (maximum)

23

0 (minimum)

25

16.104 (maximum)

25

0 (minimum)

25

16.104 (maximum)

25

(0.44 to 1.49)
-0.19
(-0.49 to 0.11)
-1.09
(-1.66 to -0.53)
-0.14
(-0.46 to 0.18)
-1.44
(-2.00 to -0.87)
-0.55
(-0.88 to -0.21)
-1.13
(-1.77 to -0.48)
-0.63
(-1.27 to 0.01)
-1.74
(-2.98 to -0.49)

23.74%

0.013

-6.65 mmol/L

23.74%

0.013

-38.15 mmol/L

39.48%

0.0005

-0.04 mmol/L

39.48%

0.0005

-0.44 mmol/L

11.11%

0.16

-1.79 mmHg

11.11%

0.16

-3.69 mmHg

3.89%

0.16

1.47 mmHg

3.89%

0.16

-4.07 mmHg

37.73% <0.0001

-3.04 cm

37.73% <0.0001

-24.71 cm

53.32% <0.0001

-0.36 mmol/L

53.32% <0.0001

5.34 mmol/l

Intervention Characteristics
Length of intervention (in weeks)

WC

HDL

TG

4 weeks
(minimum)
208 weeks
(maximum)
4 weeks
(minimum)
208 weeks
(maximum)
4 weeks
(minimum)
208 weeks
(maximum)

41
41
28
28
26
26

-0.29
(-0.52 to -0.08)
-2.42
(-3.28 to -1.57)
-0.12
(-0.33 to 0.09)
1.78
(1.11 to 2.46)
-0.20
(-0.45 to 0.04)
-1.73
(-2.50 to -0.97)

33.05%

0.0006

-7.14 mmol/L

33.05%

0.0006

-60.65 mmol/L
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FBG

SBP

DBP

Number of Females

WC

HDL

TG

FBG

SBP

4 weeks
(minimum)
208 weeks
(maximum)
4 weeks
(minimum)
208 weeks
(maximum)
4 weeks
(minimum)
208 weeks
(maximum)

24
24
26
26
26
26

0 (minimum)

38

1,154 (maximum)

38

0 (minimum)

27

1,154 (maximum)

27

0 (minimum)

25

1,154 (maximum)

25

0 (minimum)

23

1,154 (maximum)

23

0 (minimum)
1,154 (maximum)

25
25

-0.21
(-0.46 to 0.04)
-2.20
(-2.99 to -1.42)
-0.49
(-0.79 to -0.19)
-1.99
(-2.91 to -1.08)
-0.64
(-1.21 to -0.07)
-2.39
(-4.14 to -0.63)
-0.54
(-0.79 to -0.29)
-0.52
(-1.91 to 0.86)
0.28
(-0.07 to 0.64)
-2.61
(-10.47 to 5.25)
-0.40
(-0.77 to -0.03)
-2.03
(-11.42 to 7.35)
-0.53
(-0.86 to -0.21)
-0.49
(-1.9 to 0.92)
-0.69
(-0.99 to -0.39)
-0.95

50.45% <0.0001

-0.065 mmol/L

50.45% <0.0001

-0.68 mmol/L

26.15%

0.005

-1.62 mmHg

26.15%

0.005

-6.51 mmHg

6.84%

0.09

-1.49mmHg

6.84%

0.09

-5.58 mmHg

0.00%

0.98

-5.51 cm

0.00%

0.98

-5.30 cm

0.00%

0.48

0.84 mmol/L

0.00%

0.48

-1.20 mmol/L

0.00%

0.74

-14.0 mmol/L

0.00%

0.74

-71.05 mmol/L

0.00%

0.96

-0.16 mmol/L

0.00%

0.96

-0.15 mmol/L

0.00%
0.00%

0.73
0.73

-2.26 mmHg
-3.11 mmHg
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DBP

Total sample size

WC

HDL

TG

FBG

SBP

DBP

Sample size of intervention group

WC

0 (minimum)

25

1,154 (maximum)

25

12 (minimum)

41

1,406 (maximum)

41

12 (minimum)

28

1,406 (maximum)

28

12 (minimum)

26

1,406 (maximum)

26

12 (minimum)

24

1,406 (maximum)

24

12 (minimum)

26

1,406 (maximum)

26

12 (minimum)

26

1,406 (maximum)

26

11 (minimum)

41

(-2.29 to 0.41)
-0.55
(-0.86 to -0.23)
-5.83
(-7.26 to -4.41)
-0.59
(-0.87 to -0.32)
-0.51
(-1.86 to 0.84)
-0.15
(-0.55 to 0.25)
5.29
(0.07 to 10.51)
-0.17
(-0.58 to 0.23)
-5.22
(-11.02 to 0.59)
-0.49
(-0.82 to -0.17)
-0.69
(-2.07 to -0.68)
-0.72
(-1.05 to -0.39)
-0.99
(-2.37 to 0.39)
-0.39
(-0.69 to -0.94)
-5.94
(-7.22 to -4.66)
-0.59
(-0.85 to -0.34)

67.72% <0.0001

-1.29 mmHg

67.72% <0.0001

-13.64 mmHg

0.00%

0.91

-6.02 cm

0.00%

0.91

-5.20 cm

12.82%

0.05

-0.45 mmol/L

12.82%

0.05

15.87 mmol/L

7.69%

0.11

-5.95 mmol/L

7.69%

0.11

-182.7 mmol/L

0.00%

0.79

-0.15 mmol/L

0.00%

0.79

-0.21 mmol/L

0.00%

0.72

-2.35 mmHg

0.00%

0.72

-3.24 mmHg

72.57% <0.0001

-0.91 mmHg

72.57% <0.0001

-13.89 mmHg

0.00%

0.91

-6.02 cm
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HDL

TG

FBG

SBP

DBP

Use of a behavioral technique

WC

HDL

1,154 (maximum)

41

11 (minimum)

28

1,154 (maximum)

28

11 (minimum)

26

1,154 (maximum)

26

11 (minimum)

24

1,154 (maximum)

24

11 (minimum)

26

1,154 (maximum)

26

11 (minimum)

26

1,154 (maximum)
61.6 years
(maximum)

26

No

24

Yes

16

No
Yes

16
11

23

-0.51
(-1.91 to 0.89)
0.09
(-0.29 to 0.46)
2.3
(-4.69 to 9.31)
-0.31
(-0.68 to 0.06)
-4.18
(-11.8 to 3.45)
-0.51
(-0.83 to -0.19)
-0.57
(-1.95 to 0.81)
-0.73
(-1.04 to -0.41)
-0.97
(-2.36 to 0.42)
-0.49
(-0.78 to -0.20)
-5.94
(-7.24 to -4.64)
-0.32
(-1.05 to 0.41)
-0.41
(-0.71 to -0.11)
-0.73
(-1.08 to -0.38)
-0.08
(-0.42 to 0.25)
0.50

0.00%

0.91

-5.20 cm

0.00%

0.55

0.27 mmol/L

0.00%

0.55

6.9 mmol/L

0.00%

0.34

-10.85 mmol/L

0.00%

0.34

-146.3 mmol/L

0.00%

0.93

-0.16 mmol/L

0.00%

0.93

-0.18 mmol/L

0.00%

0.74

-2.39 mmHg

0.00%

0.74

-3.17 mmHg

71.86% <0.0001

-1.15 mmHg

71.86% <0.0001

-13.89 mmHg

0.85%

0.21

-1.05 mmHg

2.26%

0.17

-4.18 cm

2.26%

0.17

-7.45 cm

14.18%
14.18%

0.03
0.03

-0.24 mmol/L
1.5 mmol/L
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TG

No

16

Yes

9

No

13

Yes

9

No

15

Yes

10

DBP

No

15
10

WC

Yes
Primarily one-onone

9

HDL

Small groups
Primarily one-onone

TG

Small groups
Primarily one-onone

FBG

Small groups
Primarily one-onone

FBG

SBP

Level of intervention or supervision during the
study

19

12
9
12
7
10

(0.12 to 0.89)
-0.27
(-0.59 to 0.60)
-0.79
(-1.21 to -0.37)
-0.31
(-0.69 to 0.07)
-0.88
(-1.34 to -0.43)
-0.54
(-0.92 to -0.17)
-1.12
(-1.56 to -0.68)
-0.53
(-1.16 to 0.11)
-1.63
(-2.35 to -0.85)
-0.54
(-0.88 to -0.20)
-1.15
(-1.61 to -0.68)
-0.11
(-0.49 to 0.27)
0.64
(0.23 to 1.05)
-0.15
(-0.50 to 0.20)
-1.03
(-1.46 to -0.59)
-0.19
(-0.61 to 0.22)

9.97%

0.05

-9.45 mmol/L

9.97%

0.05

-27.65 mmol/L

11.94%

0.06

-0.09 mmol/L

11.94%

0.06

-0.27 mmol/L

11.98%

0.05

-1.77 mmHg

11.98%

0.05

-3.66 mmHg

13.48%

0.03

-1.24 mmHg

13.48%

0.03

-3.81 mmHg

16.12%

0.01

-5.51 cm

16.12%

0.01

-11.73 cm

22.31%

0.01

-0.33 mmol/L

22.31%

0.01

1.92 mmol/L

25.64%

0.006

-5.25 mmol/L

25.64%

0.006

-36.05 mmol/L

19.01%

0.03

-0.06 mmol/L
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-1.04
(-1.52 to -0.56)
19.01%
0.03
-0.46
SBP
13
0.005
(-0.83 to -0.09)
30.73%
-1.42
Small groups
7
0.005
(-1.91 to -0.94) 30.73%
-0.34
Primarily one-on(-1.02 to 0.34)
13.86%
DBP
one
13
0.05
-1.54
(-2.43 to -0.65) 13.86%
Small groups
7
0.05
Note: WC, waist circumference; HDL, HDL cholesterol; TG, triglycerides, FBG, fasting blood glucose; SBP, systolic
blood pressure; DBP, diastolic blood pressure; k is the number of interventions included in the analysis for each
outcome; R2 indicates the percentage of heterogeneity that the moderator accounts for; Clinical Unit of Measure was
calculated using a predictive model and an added metic transformation using the effect sizes for each outcome and
category.
Small groups
Primarily one-onone

7
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-0.32mmol/L
-1.50 mmHg
-4.64 mmHg
-0.79 mmHg
-3.60 mmHg

Table 5. Non-Significant Moderators

Non-Significant Moderators
Proportion of females
Proportion of participants with any type of disease
Number of participants with any type of disease
Proportion of partcipants taking any type of
medication
Number of participants taking any type of medication
Type of medication use
Experimental setting
Number of participants who dropped out of the
intervention
Length of counseling sessions
Number of counseling sessions
Specific type of diet
Publication Year
Language of publication
Recruitment type/Specific population
Proportion of carbohydrate intake (<50% or ≥50%)
Proportion of saturated fat intake (<10% or ≥10%)
Proportion of total fat intake (<30% or ≥30%)
Mean Age of the Sample
Proportion of protein intake (<15% or ≥15%)
Assessment of dietary compliance
Participation in dietary counseling
Population with cardiovascular disease
Population with Type II Diabetes Mellitus
Population with Metabolic Syndrome
Population with overweight/obesity
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Table 6. Moderators that were Unable to be analyzed due to lack of
Reported Information

Moderators Unable to be Analyzed
Oral contraceptive/hormone-replacement
therapy
Proportion of participants who smoke
Number of participants that smoke
Supplement use
Alcohol intake
Number of alcoholic drinks/week
Type of alcohol consumption
Amount of exercise/week
Type of exercise
Was dietary adherence monitored
Were medications part of the intervention
Total calories consumed on the intervention
diet
Dietary sodium intake
Dietary potassium intake
Unsaturated fat intake
Saturated fat intake
Cholesterol intake
Fiber intake
Servings of vegetables recommended
Servings of dairy recommended
Servings of wine recommended
Servings of fish recommended
Servings of olive oil recommended
Servings of legumes recommended
Servings of meat recommended
Servings of poultry recommended
Medication use
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Figure 2. Forest Plot for Waist Circumference

Note: Squares represent point estimates for each individual study; extended line
shows 95% confidence intervals (Cis); dotted line represents the null value of
zero; diamond represents the weighted mean effect size for the outcome.

52

Figure 3. Forest Plot for HDL

Note: Squares represent point estimates for each individual study; extended line
shows 95% confidence intervals (Cis); dotted line represents the null value of
zero; diamond represents the weighted mean effect size for the outcome.
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Figure 4. Forest Plot for Triglycerides

Note: Squares represent point estimates for each individual study; extended line
shows 95% confidence intervals (Cis); dotted line represents the null value of
zero; diamond represents the weighted mean effect size for the outcome.
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Figure 5. Forest Plot for Fasting Blood Glucose

Note: Squares represent point estimates for each individual study; extended line
shows 95% confidence intervals (Cis); dotted line represents the null value of
zero; diamond represents the weighted mean effect size for the outcome.
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Figure 6. Forest Plot for Systolic Blood Pressure

Note: Squares represent point estimates for each individual study; extended line
shows 95% confidence intervals (Cis); dotted line represents the null value of
zero; diamond represents the weighted mean effect size for the outcome.
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Figure 7. Forest Plot for Diastolic Blood Pressure

Note: Squares represent point estimates for each individual study; extended line
shows 95% confidence intervals (Cis); dotted line represents the null value of
zero; diamond represents the weighted mean effect size for the outcome.
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Figure 8. Meta-Regression Plot for Waist Circumference

B= -0.0104
CI=(-0.015, -0.0057)
2
R = 37.7%

Note: Number of weeks of the intervention is represented on the x-axis; Outcome
of interest is represented on the y-axis; B is the unstandardized beta and
represents the amount of change in the outcome per week of the intervention; R2
indicates the percentage of variability accounted for by length.

58

Figure 9. Meta-Regression Plot for HDL

B= 0.0093
CI=(0.0056, 0.0131)
2
R = 53.32%

Note: Number of weeks of the intervention is represented on the x-axis; Outcome
of interest is represented on the y-axis; B is the unstandardized beta and
represents the amount of change in the outcome per week of the intervention; R2
indicates the percentage of variability accounted for by length.
Figure 10. Meta-Regression Plot for Triglycerides

B= -0.0075
CI=(-0.0118, -0.0032)
2
R = 33.1%

Note: Number of weeks of the intervention is represented on the x-axis; Outcome
of interest is represented on the y-axis; B is the unstandardized beta and
represents the amount of change in the outcome per week of the intervention; R2
indicates the percentage of variability accounted for by length.
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Figure 11. Meta-Regression Plot for Fasting Blood Glucose

B= -0.0098
CI=(-0.0141, -0.0054)
2
R = 50.45%

Note: Number of weeks of the intervention is represented on the x-axis; Outcome
of interest is represented on the y-axis; B is the unstandardized beta and
represents the amount of change in the outcome per week of the intervention; R2
indicates the percentage of variability accounted for by length.
Figure 12. Meta-Regression Plot for Systolic Blood Pressure

B= -0.0073
CI=(-0.0125, -0.0022)
2
R = 26.2%

Note: Number of weeks of the intervention is represented on the x-axis; Outcome
of interest is represented on the y-axis; B is the unstandardized beta and
represents the amount of change in the outcome per week of the intervention; R2
indicates the percentage of variability accounted for by length.
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Figure 13. Meta-Regression
Regression Plot for Diastolic Blood Pressure

Note: Number of weeks of the intervention is represented on the xx-axis;
axis; Outcome
of interest is represented on the yy-axis; B is
s the unstandardized beta and
represents the amount of change in the outcome per week of the intervention; R2
indicates the percentage of variability accounted for by length.
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Figure 14. Risk of Bias
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Appendix
Appendix 1. Comprehensive Literature Search Strategy
All databases searched until August 4, 2014.
1. PubMed, years 1940s-present
Terms were searched in all fields; however, field labels were used to
restrict specific terms/phrases to the Medical Subject Headings [Mesh],
publication type [pt] and journal name [ta] fields.
(“Mediterranean diet” OR "Mediterranean diets" OR “Mediterranean dietary” OR
"Mediterranean style diet" OR "Mediterranean style diets" OR "Diet,
Mediterranean"[Mesh]) AND (adiposity OR "metabolic syndrome" OR overweight
OR BMI OR "body mass" OR "waist circumference" OR weight [tiab] OR “body
weight” OR obese OR obesity OR "abdominal fat" OR "Weight Loss"[Mesh] OR
“weight loss” OR "Diet, Reducing"[Mesh]) NOT ("Cross-Sectional Studies"[MeSH
Terms] OR "Case Reports"[pt] OR Comment[pt] OR Editorial[pt] OR Letter[pt] OR
Review[pt] OR "case control"[ti] OR "case report"[ti] OR "case study"[ti] OR "case
series"[ti] OR "Case-Control Studies"[Mesh] OR "Follow-Up Studies"[Mesh] OR
"observational study"[ti] OR "prospective cohort"[ti] OR "cohort
studies"[Mesh:noexp] OR "cohort study"[ti] OR "Longitudinal
Studies"[Mesh:noexp] OR "Follow-Up Studies"[mesh] OR "Retrospective
Studies"[mesh] OR "non-randomized"[ti] OR "follow up study"[ti] OR rat[ti] OR
rats[ti] OR mice[ti] OR mouse[ti] OR dog[ti] OR dogs[ti] OR cats[ti])
Results: 431
2. EMBASE (via Scopus) years 1823-present
All terms were searched in “Article Title, Abstract, Keywords”. Because of
character restrictions in Scopus, this search was run in parts and
assembled using the “Search history”.
Limit to Document type: “Article”
{Mediterranean diet} OR {Mediterranean diets} OR {Mediterranean dietary} OR
{Mediterranean style diet} OR {Mediterranean style diets}
AND (adiposity OR {weight loss} OR {metabolic syndrome} OR overweight OR
BMI OR {body mass} OR {waist circumference} OR weight OR {body weight} OR
obese OR obesity OR {abdominal fat})
NOT (in article title) ({Cross-Sectional Studies} OR {Case Reports} OR Comment
OR Editorial OR Letter OR Review OR {case control} OR {case report} OR {case
study} OR {case series} OR {Follow-Up Study} OR {observational study} OR
{prospective cohort} OR {cohort study} OR {Longitudinal Study} OR {Follow-Up
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Studies} OR {Retrospective Studies} OR {non-randomized} OR {follow up study}
OR rat OR rats OR mice OR mouse OR dog OR dogs OR cats)
Results: 515
3. Web of Science, years 1974-present
All terms were searched in “Topic”.
Limit to Document type: “article”
"Mediterranean diet" OR "Mediterranean diets" OR "Mediterranean dietary" OR
"Mediterranean style diet" OR "Mediterranean style diets"
AND
(adiposity OR "weight loss" OR "metabolic syndrome" OR overweight OR BMI
OR "body mass" OR "waist circumference" OR weight OR "body weight" OR
obese OR obesity OR "abdominal fat")
NOT (in title) ("Cross-Sectional Studies" OR "Case Reports" OR Comment OR
Editorial OR Letter OR Review OR "case control" OR "case report" OR "case
study" OR "case series" OR "Follow-Up Study" OR "observational study" OR
"prospective cohort" OR "cohort study" OR "Longitudinal Study" OR "Follow-Up
Studies" OR "Retrospective Studies" OR "non-randomized" OR "follow up study"
OR rat OR rats OR mice OR mouse OR dog OR dogs OR cats)
Results: 890
4. CINAHL
All terms were searched in all fields.
Excluded: MEDLINE Records
Limited to: research articles
"Mediterranean diet" OR "Mediterranean diets" OR "Mediterranean dietary" OR
"Mediterranean style diet" OR "Mediterranean style diets"
AND
(adiposity OR "weight loss" OR "metabolic syndrome" OR overweight OR BMI
OR "body mass" OR "waist circumference" OR weight OR "body weight" OR
obese OR obesity OR "abdominal fat")
NOT (in title) ("Cross-Sectional Studies" OR "Case Reports" OR Comment OR
Editorial OR Letter OR Review OR "case control" OR "case report" OR "case
study" OR "case series" OR "Follow-Up Study" OR "observational study" OR
"prospective cohort" OR "cohort study" OR "Longitudinal Study" OR "Follow-Up
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Studies" OR "Retrospective Studies" OR "non-randomized" OR "follow up study"
OR rat OR rats OR mice OR mouse OR dog OR dogs OR cats)
Results : 25
5. Agricola years 1970-present
Searched in “All Fields”
Limited to “academic journals”
"Mediterranean diet" OR "Mediterranean diets" OR "Mediterranean dietary" OR
"Mediterranean style diet" OR "Mediterranean style diets"
AND
(adiposity OR "weight loss" OR "metabolic syndrome" OR overweight OR BMI
OR "body mass" OR "waist circumference" OR weight OR "body weight" OR
obese OR obesity OR "abdominal fat")
NOT (in title) ("Cross-Sectional Studies" OR "Case Reports" OR Comment OR
Editorial OR Letter OR Review OR "case control" OR "case report" OR "case
study" OR "case series" OR "Follow-Up Study" OR "observational study" OR
"prospective cohort" OR "cohort study" OR "Longitudinal Study" OR "Follow-Up
Studies" OR "Retrospective Studies" OR "non-randomized" OR "follow up study"
OR rat OR rats OR mice OR mouse OR dog OR dogs OR cats)
Results: 123
6. CAB Direct years 1973-present
Limit to Document Type: Journal article
"Mediterranean diet" OR "Mediterranean diets" OR "Mediterranean dietary" OR
"Mediterranean style diet" OR "Mediterranean style diets"
AND
(adiposity OR "weight loss" OR "metabolic syndrome" OR overweight OR BMI
OR "body mass" OR "waist circumference" OR weight OR "body weight" OR
obese OR obesity OR "abdominal fat")
NOT (in title) ("Cross-Sectional Studies" OR "Case Reports" OR Comment OR
Editorial OR Letter OR Review OR "case control" OR "case report" OR "case
study" OR "case series" OR "Follow-Up Study" OR "observational study" OR
"prospective cohort" OR "cohort study" OR "Longitudinal Study" OR "Follow-Up
Studies" OR "Retrospective Studies" OR "non-randomized" OR "follow up study"
OR rat OR rats OR mice OR mouse OR dog OR dogs OR cats)
Results: 423; TOTAL: 1,269 after removal of duplicates

65

Appendix 2. Screening Form
Study ID: _________
Coder: __________
Mediterranean Diet Obesity Meta-Analysis Selection Criteria
Inclusion Criteria
Exclusion Criteria
Trials MUST match all of these criteria:
Studies CANNOT include any of the
following:
Pre- AND Post-intervention weight
measurements (at least one of
these):

Waist Circumference



Mediterranean diet (as a whole, for
example, not just olive oil) for at least
one of the interventions. Can also be
described as Mediterranean-style diet,
hypocaloric Mediterranean diet, etc.

Survey



Review



Guidelines



Prospective Studies



Epidemiologic Studies



Cross-sectional Studies





Notes:
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Appendix 3. Mediterranean Diet Coding Form (finalized July
2014)
CODER________

Coder (Marissa=1, Julia=2, Other=3)

Study Information
ID _______ Study ID (first 3 letters of 1st author’s last name & unique ID#: Pescatello=
PES001), ___________________ (Last name, Yr)
PUB_YR ________ Publication year (consider this missing if unpublished)
DATA ________ Estimated year of data collection (earliest date for data collection
or manuscript submission/publication;
if unpublished and date unknown, use year manuscript was acquired;
for dissertation or thesis, use year)
LANG ________ Language of report
1=English 2=Spanish 3=Japanese
4=Other, specify: _________________________
SOURCE________ Publication Type 1=journal 2=book 3=thesis/dissertation
4=conference paper 5= unpublished
SCORE ________ Impact Score of the Journal (use ISI Web of Knowledge journal
citation reports)
JOURNAL NAME
_____________________________________________________________________
____
PUBMED NAME/ ABBR.
_________________________________________________________________
FUNDING SOURCE_______ 1= Gov’nt (i.e., CDC, NIH, etc) 2= Academic/University
3= Private 4= Other
For all, specify source/grant:
___________________________________________________
_______________________________
___________________________________________________
___________________________________
NOTE_STUDY________ study notes (make note of multiple arms; ex. MD vs. low fat
vs. low carb + MD vs. CONTROL): _____
_______________________________________________________________________
__________________________
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Sample Characteristics (proportion: 0.0- 1.0) Note: IF ethnicity is reported, ETH_EST
will be == 0
ETH ________ Ethnicity reported?

1 = yes; 0 = no

PROP_WH ______
Proportion White; whole #____
PROP_BLK ______
Proportion Black/ whole #____
PROP_ASIAN ______
Proportion Asian/ whole #____
PROP_MIX
______
Proportion Mixed (other)/ whole #____
PROP_HISP ______
PROP_CARIB

Proportion Latino/Hispanic/ whole #____

______

Proportion Caribbean/ whole #____

ETH_EST
________ Assumed ethnicity (0= n/a, 1= White, 2= Asian, 3=
Black, 4= Unreported, 5= Hispanic/Latino)
NUM_FemCON
________ # of Females in Sample; Proportion
(#⁄ :___________
NUM_FemIN1
________ # of Females in Sample; Proportion
(#⁄ :___________
NUM_FemIN2
________ # of Females in Sample; Proportion
(#⁄ :___________
NUM_FemIN3 ________ # of Females in Sample; Proportion
(#⁄ :___________

REGION________ Location of sample (if unreported, use location of first author
as estimate of study location)
1=American city: __________________
US_ZIP_______
2=other US region (city= unreported):_____________
3=Canada (city: _______________________)
4=Europe (city: _______________________)
5=South/Central America, Mexico, Caribbean (city: _______________)
6=Africa (city: _______________________)
7=Asia (city: Osaka, Japan)
(city: _______________________)

POP ________ Population 0=not reported
1=school/college
(senior center, flyers, etc.) ________________

8=Australia

2=community
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3= clinical/hospital (e.g., cardiac rehab, outpatient clinic, etc.)
_______________________________
NOTE_RECRUIT
Notes on recruitment/ sample location
__________________________________________________
Risk Characteristics- report values of baseline data (check methods or descriptive
tables) KEEP DATA SEPARATE FOR GROUPS
TOTAL_POP
________ Reported as total sample? (1=yes, 0=no) *if data is
collapsed, not separate for groups, chose YES
CONTROL
IN1 n=____
IN2 n=____
IN3 n=____
/
(total
(total
(total
COMPARI
sample),
sample),
sample),
SON
specify
specify
specify
Characteristic
n=____
intervent
interventio
intervent
ion_____
ion_____
(total
n________
_
_
sample
)
Mean age
AGE
AGE
AGE
AGE
(years)
SD for age
AGE_SD
AGE_SD
AGE_SD
AGE_SD
(years)
Known disease/
chronic
conditions
0= Healthy
3= CVD(s) (i.e.,
CAD, PAD,
HF, MI)
4= Stroke
5=
Diabetes
6= MetS
DISEASE
DISEASE
DISEASE
DISEASE
7= Arthritis
8= Dyslipidemia
9= Obesity
10= Other,
specify:_____
__________
11= Multiple,
specify
#s:________
___
If disease: report PROP_DIS PROP_DISE PROP_DISEA PROP_DISE
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Characteristic

prop. &
number
if “healthy”
denote 0=
n/a; if
missing=“.”
Medication use
(0=no, 1=
yes)
If yes, report
prop &
number; if
no meds,
use 0=NA (if
missing =“.”)
Medication
Type (if no
meds= 0)
1= β Blockers
2=
Nitrates
3= Ca+2
Channel
Blockers
4= Angiotension
Converting
Enzyme
(ACE)
Inhibitors
5= Diuretics
6=
Vasodilators
7= NSAIDs
8= Aspirin
9= Statins
10=Other,
specify:

CONTROL
/
COMPARI
SON
n=____
(total
sample
)
EASE
NumberDis
ease

IN1 n=____
(total
sample),
specify
intervent
ion_____
_

IN2 n=____
(total
sample),
specify
interventio
n________

IN3 n=____
(total
sample),
specify
intervent
ion_____
_

ASE
NumberDise
ase

SE
NumberDiseas
e

ASE
NumberDise
ase

MED

MED

MED

MED

PROP_US
E
NumberME
D

PROP_USE
NumberMED

PROP_USE
NumberMED

PROP_USE
NumberMED

MED_TYP
E

MED_TYPE

MED_TYPE

MED_TYPE
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Characteristic

CONTROL
/
COMPARI
SON
n=____
(total
sample
)

11= Multiple,
specify:
________
BP Medication
BPMedUse
use (1= yes,
0=no)
If unreported ==
“.”
If yes, report
BPMedPro
prop. &
p
number
BPMedNu
(if “no”=0,
mber
NA; if
missing
denote=“.”)
If taking meds,
is BP
controlled?
yes= 1, if
SBP≤140
OR
BPControl
DBP≤90;
no= 0,
SBP>140
OR DBP>90
(*if no BP
use == NA)
LIFESTYLE VARIABLES
Oral
OC_USE
Contraceptiv
HRT_U
e (0=no, 1=
SE
yes)
OR Hormone
replacement
therapy
Smokers/smok
SMOKE
ers (≤6

IN1 n=____
(total
sample),
specify
intervent
ion_____
_

IN2 n=____
(total
sample),
specify
interventio
n________

IN3 n=____
(total
sample),
specify
intervent
ion_____
_

BPMedUse

BPMedUse

BPMedUse

BPMedProp
BPMedNumb
er

BPMedProp
BPMedNumbe
r

BPMedProp
BPMedNumb
er

BPControl

BPControl

BPControl

OC_USE
HRT_USE

OC_USE
HRT_USE

OC_USE
HRT_USE

SMOKE

SMOKE

SMOKE
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Characteristic

months)
(0=no,1=yes
; if missing =
“.”)
If yes, report
smoker
prop. &
number
Nutritional
Supplement
s
Permitted?
(0=no,
1=yes)
If yes, specify
type
Consume
Alcohol?
(0=no,
1=yes)
If yes, how
many
drinks/week
?
If yes, what
type of
alcohol?
Amount of
exercise
per week
(in min)
Type of
exercise
(e.g.,
cardio,
strength
training)

CONTROL
/
COMPARI
SON
n=____
(total
sample
)

IN1 n=____
(total
sample),
specify
intervent
ion_____
_

IN2 n=____
(total
sample),
specify
interventio
n________

IN3 n=____
(total
sample),
specify
intervent
ion_____
_

PROP_SM
OKE
NumberSM
OKE

PROP_SMO
KE
NumberSMO
KE

PROP_SMOK
E
NumberSMOK
E

PROP_SMO
KE
NumberSMO
KE

SUPP

SUPP

SUPP

SUPP

TYPE

TYPE

TYPE

TYPE

ALC

ALC

ALC

ALC

AMT

AMT

AMT

AMT

ALCTYPE

ALCTYPE

ALCTYPE

ALCTYPE

EX

EX

EX

EX
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NOTE_RISK
Notes on risk characteristics relevant to coding
_____________________________________________
Methods & Design
CON_GRP
________ Type of control group used
1= random assignment of individuals to conditions including a non-diet
control group, specify_________________
2= random assignment of individuals to conditions including non-diet
control session
3= random assignment of individuals to non-MD condition/diet
4= random assignment of individuals a non-diet control group
5= other, specify:
_______________________________________________________________
_______
Experiment/ Intervention Conditions
EXPERIMENT________ INTERVENTIONS/EXPERIMENTAL CONDITION(S)
1= non-diet control/comparison + 1 intervention
control/comparison + 2 interventions
3= non-diet control/comparison + 3 interventions
4= diet control/comparison + 1 intervention
+ 2 interventions
6= diet control/comparison + 3 interventions

2= non-diet

5= diet control/comparison

EXP_SETTING________ Setting of Intervention(s) 1= hospital
2= clinic
3= academic/research lab
4= fitness center, gym
5= Other, specify: ___________________________________
6=
multiple, specify:__________
DIET_MONITOR________ Was diet adherence monitored? (0= none; 1= yes)
If yes, specify:
__________________________________________________________________
________________________________________
BEHAV_TECH__________Behavioral technique/monitoring system
used?(0=none, 1=yes) If yes, specify__________________________________________________________________
________________________________________
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Examples: positive reinforcement/contingency management, exercise & lifestyle
information/lectures; PA logs, etc.
INTER_LVL________ Level of intervention or supervision used in the study
1=primarily 1-on-1
2=small group processes (supervisor & group members)
3= supervised session(s)
4= unsupervised session(s) 5=incentive (payment based on sessions attended)
6= multiply, specify #’s:_____________________________
NOTE_EXP & METHODS
Notes related to study design & delivery of
intervention: ____________________________
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DIET CHARACTERISTICS
LENGTH___(in weeks)
WTGain/WTLoss___
(1=loss, 2=gain, 3=maintain,
4=unspecified)
PART_LOST # of drop outs

CONTROL/
COMPARISON
LENGTH__

LENGTH__

LENGTH__

LENGTH__

WTGain/WTLoss___

WTGain/WTLoss___

WTGain/WTLoss___

WTGain/WTLoss___

MEDS__

MEDS__

MED__TYPE

MED__TYPE

MED__TYPE

DIET__TYPE

DIET__TYPE

DIET__TYPE

ADHERENCE (report %) If
reported as # of sessions
completed, use==
 
(
x 100)
 
Were medications used as part
of the intervention? (0=no,
MEDS__
1=yes)
If yes, specify
1= β Blockers
2= Nitrates
+2
3= Ca Channel Blockers
4= Angiotension Converting
Enzyme (ACE) Inhibitors
MED__TYPE
5= Diuretics
6=
Vasodilators
7= NSAIDs
8= Aspirin
9= Statins
10=Other,
specify:
11= Multiple, specify: ________
DIET__TYPE
(1=MedDiet, 2=low-fat, 3=high
DIET__TYPE
protein, 4=low-carb,
5=other, specify)
Provision of Med Diet Foods? (0=no, 1=yes)

IN1

MEDS__

IN2

IN3

If yes, type and amount___
1=olive oi (amt:____)
2=nuts (amt:___)
3=fruits (amt:___)
4=fish (amt:___)
5=dairy (amt:___)
6=multiple
Diet specification reported as a distribution of macronutrients? (0=no, 1=yes)
If yes, specify
PropCHO___
PropSatFAT___
PropTotFAT___
PropPRO___
KCAL_TOTAL_BASE(kcal/day)
KCAL_TOTAL_END (kcal/day)
KCAL_Rx Prescribed kcals per
day
KCAL_REPORT Reported kcals
per day
Energy restriction (kcal or %)

PropCHO___
PropSatFAT___
PropTotFAT___
PropPRO___

PropCHO___
PropSatFAT___
PropTotFAT___
PropPRO___

PropCHO___
PropSatFAT___
PropTotFAT___
PropPRO___

PropCHO___
PropSatFAT___
PropTotFAT___
PropPRO___

____________
___________
____________
____________

____________
___________
____________
____________

____________
___________
____________
____________

____________
___________
____________
____________

____________
____________
____________

____________
____________
____________

____________
____________
____________

____________
____________
____________

KCAL_RES (unit= kcal) OR
RES_PERCENT (%)
SOD_INTAKE (mg/day)
POT_INTAKE (mg/day)
FAT_INTAKE (g/day)
Unsaturated: FAT_UNSAT
Saturated:
FAT_SAT
Cholesterol: FAT_CHOL
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Dietary Fiber Intake (g/day)
FIB_INTAKE
Servings/week: Fruit and/or
Vegetables
VEG_SER
Servings/week: Dairy
DAIRY_SER
Servings/week: Wine
WINE_SER
Servings/week: Whole Grains
GRAIN_SER
Servings/week: Fish
FISH_SER
Servings/week: Olive Oil
OIL_SER
Servings/week: Nuts
NUTS_SER
Servings/week: Legumes
LEG_SER
Servings/week: Red/processed
meat MEAT_SER
Servings/week: Poultry
POUL_SER
Dietary Compliance & Counseling
DI_COMPLIANCE Was Dietary
compliance assessed? 0=
No; 1= Yes)
If yes, specify:
(1=FFQ, 2=Food journal,
3=phone interviewing, 4=24
hr recall,
5=other,specify___)
Was diet adherence measured
pre, during, or post
intervention? (1=pre,
2=during, 3=post,
4=pre,during, and post,
5=pre and post, 6=not
reported)
Is a scale used to measure
adherence? (0=no, 1=yes)
If yes, specify type of scale
used___
DI_COUNSELING Participation
in dietary counseling? 0= no;
1= yes
If Dietary Counseling was
provided, report:
COUNSEL_HR hours per week
COUNSEL_SESS sessions per
week
DIET_TOPIC If Dietary
Counseling was provided,

____________

____________

____________

____________

____________

____________

____________

____________
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briefly state topics covered
QoL Was Quality of Life (QoL)
assessed? 0=no, 1=yes, if
yes, report tool or scale
NOTE_DIET Report here any notes relevant to the dietary intervention, counseling, implementation, etc.

# of follow-ups
Interval of follow-ups
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Appendix 4. SAS Code
Import Data
To read data set:
proc print data=midterm;
run;
To get mean, range, and standard deviation of certain variables (various dummy
codes were created in Excel prior to analysis):
proc means data=midterm n sum mean max min range std;
class Diet Article;
run;
To calculate percentages for language and region of publication:
proc freq data=midterm;
run;
Age of participants was in a separate spreadsheet (weighted mean and std of
age was calculated by hand):
proc print data=age;
run;
proc means data=age n sum mean max min range std;
run;
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Appendix 5. R Syntax
Run the Library
Library(“metafor”)
Overall Effect Sizes
#TMD and WC
model1<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==1), data=Final,
method="FE")
model1
model2<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==1), data=Final,
method="REML", slab= paste(Reference, Year, sep=""))
model2
#TMD and HDL
model5<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), data=Final,
method="FE")
model5
model6<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), data=Final,
method="REML", slab= paste(Reference, Year, sep=""))
model6
#TMD and triglycerides
model7<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), data=Final,
method="FE")
model7
model8<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), data=Final,
method="REML", slab= paste(Reference, Year, sep=""))
model8
#TMD and glucose
model9<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), data=Final,
method="FE")
model9
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model10<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), data=Final,
method="REML", slab= paste(Reference, Year, sep=""))
model10
#TMD and SBP
model11<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), data=Final,
method="FE")
model11
model12<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), data=Final,
method="REML", slab= paste(Reference, Year, sep=""))
model12
#TMD and DBP
model13<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), data=Final,
method="FE")
model13
model14<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), data=Final,
method="REML", slab= paste(Reference, Year, sep=""))
model14
Forest Plots
#this determines the xleft, xright, ybottom, ytop in the plot in order to use
this information to determine where to instert text
#TMD and WC
par("usr")
forest(model2, xlim=c(-10,10), xlab="Standardized Mean Difference", cex=0.8,
efac=2, col="dark red", border="black")
op<-par(cex=0.85, font=2, col="black")#to change the size, font, and color of the
plot
op<-par(cex=0.85, font=2, col="dark red") #to change the size, the font, and the
color of the inserted text in the plot
text (0,45, "Waist Circumference") #the first number indicates where the title
starts and the second number how high in the plot
text(c(-4,4),44,c("Favors Intervention", "Favors Baseline")) #here the -8 is telling
us the position where favors intervention starts and 7 where the position where
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favors baseline starts, and they both are at the 22 height in the plot, if you count
the number of authors are 20, plus the line where RE Model is that is 21 rows, so
the labels Author, and Favors are in line 22
text(-10,44, "Author(s) and Year", pos=4)
text(7.5,44, "d[95%CI]", pos=4)
par(op)
#TMD and HDL
par("usr")
forest(model6, xlim=c(-10,10), xlab="Standardized Mean Difference", cex=0.8,
efac=2, col="dark red", border="black")
op<-par(cex=0.85, font=2, col="black")#to change the size, font, and color of the
plot
op<-par(cex=0.85, font=2, col="dark red") #to change the size, the font, and the
color of the inserted text in the plot
text (0,31, "HDL") #the first number indicates where the title starts and the
second number how high in the plot
text(c(-3,3),30,c("Favors Baseline ", "Favors Intervention")) #here the -8 is telling
us the position where favors intervention starts and 7 where the position where
favors baseline starts, and they both are at the 22 height in the plot, if you count
the number of authors are 20, plus the line where RE Model is that is 21 rows, so
the labels Author, and Favors are in line 22
text(-10,30, "Author(s) and Year", pos=4)
text(8,30, "d[95%CI]", pos=4)
par(op)
#TMD and TG
par("usr")
forest(model8, xlim=c(-10,10), xlab="Standardized Mean Difference", cex=0.8,
efac=2, col="dark red", border="black")
op<-par(cex=0.85, font=2, col="black")#to change the size, font, and color of the
plot
op<-par(cex=0.85, font=2, col="dark red") #to change the size, the font, and the
color of the inserted text in the plot
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text (0,29, "Triglycerides") #the first number indicates where the title starts and
the second number how high in the plot
text(c(-4,4),28,c("Favors Intervention", "Favors Baseline")) #here the -8 is telling
us the position where favors intervention starts and 7 where the position where
favors baseline starts, and they both are at the 22 height in the plot, if you count
the number of authors are 20, plus the line where RE Model is that is 21 rows, so
the labels Author, and Favors are in line 22
text(-10,28, "Author(s) and Year", pos=4)
text(8,28, "d[95%CI]", pos=4)
par(op)
#TMD and FBG
par("usr")
forest(model10, xlim=c(-10,10), xlab="Standardized Mean Difference", cex=0.8,
efac=2, col="dark red", border="black")
op<-par(cex=0.85, font=2, col="black")#to change the size, font, and color of the
plot
op<-par(cex=0.85, font=2, col="dark red") #to change the size, the font, and the
color of the inserted text in the plot
text (0,27, "Glucose") #the first number indicates where the title starts and the
second number how high in the plot
text(c(-4,4),26,c("Favors Intervention", "Favors Baseline")) #here the -8 is telling
us the position where favors intervention starts and 7 where the position where
favors baseline starts, and they both are at the 22 height in the plot, if you count
the number of authors are 20, plus the line where RE Model is that is 21 rows, so
the labels Author, and Favors are in line 22
text(-10,26, "Author(s) and Year", pos=4)
text(8,26, "d[95%CI]", pos=4)
par(op)
#TMD and SBP
par("usr")
forest(model12, xlim=c(-10,10), xlab="Standardized Mean Difference", cex=0.8,
efac=2, col="dark red", border="black")
op<-par(cex=0.85, font=2, col="black")#to change the size, font, and color of the
plot
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op<-par(cex=0.80, font=2, col="dark red") #to change the size, the font, and the
color of the inserted text in the plot
text (0,29, "Systolic Blood Pressure") #the first number indicates where the title
starts and the second number how high in the plot
text(c(-4,4),28,c("Favors Intervention", "Favors Baseline")) #here the -8 is telling
us the position where favors intervention starts and 7 where the position where
favors baseline starts, and they both are at the 22 height in the plot, if you count
the number of authors are 20, plus the line where RE Model is that is 21 rows, so
the labels Author, and Favors are in line 22
text(-10,28, "Author(s) and Year", pos=4)
text(8,28, "d[95%CI]", pos=4)
par(op)
#TMD and DBP
par("usr")
forest(model14, xlim=c(-10,10), xlab="Standardized Mean Difference", cex=0.8,
efac=2, col="dark red", border="black")
op<-par(cex=0.85, font=2, col="black")#to change the size, font, and color of the
plot
op<-par(cex=0.85, font=2, col="dark red") #to change the size, the font, and the
color of the inserted text in the plot
text (0,29, "Diastolic Blood Pressure") #the first number indicates where the title
starts and the second number how high in the plot
text(c(-4,4),28,c("Favors Intervention", "Favors Baseline")) #here the -8 is telling
us the position where favors intervention starts and 7 where the position where
favors baseline starts, and they both are at the 22 height in the plot, if you count
the number of authors are 20, plus the line where RE Model is that is 21 rows, so
the labels Author, and Favors are in line 22
text(-10,28, "Author(s) and Year", pos=4)
text(8,28, "d[95%CI]", pos=4)
par(op)
Publication Bias
#pub bias for med Diet and WC
#Egger's
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regtest(model2, model="lm", data=Final)
#Begg's
ranktest(model2, data=Final)
#funnel plot
model2trim=trimfill(model2, data=Final)
funnel(model2trim)
#pub bias for med Diet and HDL
#Egger's
regtest(model6, model="lm", data=Final)
#Begg's
ranktest(model6, data=Final)
#funnel plot
model6trim=trimfill(model6, data=Final)
funnel(model6trim)
#pub bias for med Diet and Triglyceride
#Egger's
regtest(model8, model="lm", data=Final)
#Begg's
ranktest(model8, data=Final)
#funnel plot
model8trim=trimfill(model8, data=Final)
funnel(model8trim)
#pub bias for med Diet and Glucose
#Egger's
regtest(model10, model="lm", data=Final)
#Begg's
ranktest(model10, data=Final)
#funnel plot
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model10trim=trimfill(model10, data=Final)
funnel(model10trim)
#pub bias for med Diet and SBP
#Egger's
regtest(model12, model="lm", data=Final)
#Begg's
ranktest(model12, data=Final)
#funnel plot
model12trim=trimfill(model12, data=Final)
funnel(model12trim)
#pub bias for med Diet and DBP
#Egger's
regtest(model14, model="lm", data=Final)
#Begg's
ranktest(model14, data=Final)
#funnel plot
model14trim=trimfill(model14, data=Final)
funnel(model14trim)
Syntax to create subsets
tmdwc<-subset(Final, Diet==1 & Out==1)
tmdhdl<-subset(Final, Diet==1 & Out==3)
tmdtg<-subset(Final, Diet==1 & Out==4)
tmdfbg<-subset(Final, Diet==1 & Out==5)
tmdsbp<-subset(Final, Diet==1 & Out==6)
tmddbp<-subset(Final, Diet==1 & Out==7)
Risk of Bias
#RanSeq-1
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model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(RanSeq)-1, data=Quality, method="REML")
summary(model53)
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(RanSeq)-1, data=Quality, method="REML")
summary(model54)
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(RanSeq)-1, data=Quality, method="REML")
summary(model55)
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(RanSeq)-1, data=Quality, method="REML")
summary(model56)
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(RanSeq)-1, data=Quality, method="REML")
summary(model57)
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(RanSeq)-1, data=Quality, method="REML")
summary(model58)
#RanSeq
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(RanSeq), data=Quality, method="REML")
summary(model53)
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(RanSeq), data=Quality, method="REML")
summary(model54)
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(RanSeq), data=Quality, method="REML")
summary(model55)
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(RanSeq), data=Quality, method="REML")
summary(model56)
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model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(RanSeq), data=Quality, method="REML")
summary(model57)
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(RanSeq), data=Quality, method="REML")
summary(model58)
#AllCon-1
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(AllCon)-1, data=Quality, method="REML")
summary(model53)
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(AllCon)-1, data=Quality, method="REML")
summary(model54)
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(AllCon)-1, data=Quality, method="REML")
summary(model55)
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(AllCon)-1, data=Quality, method="REML")
summary(model56)
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(AllCon)-1, data=Quality, method="REML")
summary(model57)
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(AllCon)-1, data=Quality, method="REML")
summary(model58)
# AllCon
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(AllCon), data=Quality, method="REML")
summary(model53)
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(AllCon), data=Quality, method="REML")
summary(model54)
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model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(AllCon), data=Quality, method="REML")
summary(model55)
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(AllCon), data=Quality, method="REML")
summary(model56)
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(AllCon), data=Quality, method="REML")
summary(model57)
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(AllCon), data=Quality, method="REML")
summary(model58)
#Blinding-1
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(Blinding)-1, data=Quality, method="REML")
summary(model53)
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(Blinding)-1, data=Quality, method="REML")
summary(model54)
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(Blinding)-1, data=Quality, method="REML")
summary(model55)
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(Blinding)-1, data=Quality, method="REML")
summary(model56)
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(Blinding)-1, data=Quality, method="REML")
summary(model57)
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(Blinding)-1, data=Quality, method="REML")
summary(model58)
# Blinding
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model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(Blinding), data=Quality, method="REML")
summary(model53)
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(Blinding), data=Quality, method="REML")
summary(model54)
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(Blinding), data=Quality, method="REML")
summary(model55)
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(Blinding), data=Quality, method="REML")
summary(model56)
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(Blinding), data=Quality, method="REML")
summary(model57)
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(Blinding), data=Quality, method="REML")
summary(model58)
#Incomp-1
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(Incomp)-1, data=Quality, method="REML")
summary(model53)
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(Incomp)-1, data=Quality, method="REML")
summary(model54)
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(Incomp)-1, data=Quality, method="REML")
summary(model55)
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(Incomp)-1, data=Quality, method="REML")
summary(model56)
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model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(Incomp)-1, data=Quality, method="REML")
summary(model57)
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(Incomp)-1, data=Quality, method="REML")
summary(model58)
#Incomp
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(Incomp), data=Quality, method="REML")
summary(model53)
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(Incomp), data=Quality, method="REML")
summary(model54)
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(Incomp), data=Quality, method="REML")
summary(model55)
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(Incomp), data=Quality, method="REML")
summary(model56)
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(Incomp), data=Quality, method="REML")
summary(model57)
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(Incomp), data=Quality, method="REML")
summary(model58)
#Select
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(Select), data=Quality, method="REML")
summary(model53)
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(Select), data=Quality, method="REML")
summary(model54)
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model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(Select), data=Quality, method="REML")
summary(model55)
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(Select), data=Quality, method="REML")
summary(model56)
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(Select), data=Quality, method="REML")
summary(model57)
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(Select), data=Quality, method="REML")
summary(model58)
#Select-1
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(Select)-1, data=Quality, method="REML")
summary(model53)
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(Select)-1, data=Quality, method="REML")
summary(model54)
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(Select)-1, data=Quality, method="REML")
summary(model55)
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(Select)-1, data=Quality, method="REML")
summary(model56)
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(Select)-1, data=Quality, method="REML")
summary(model57)
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(Select)-1, data=Quality, method="REML")
summary(model58)
#OtherBias-1
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model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(OtherBias)-1, data=Quality, method="REML")
summary(model53)
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(OtherBias)-1, data=Quality, method="REML")
summary(model54)
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(OtherBias)-1, data=Quality, method="REML")
summary(model55)
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(OtherBias)-1, data=Quality, method="REML")
summary(model56)
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(OtherBias)-1, data=Quality, method="REML")
summary(model57)
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(OtherBias)-1, data=Quality, method="REML")
summary(model58)
#OtherBias
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(OtherBias), data=Quality, method="REML")
summary(model53)
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(OtherBias), data=Quality, method="REML")
summary(model54)
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(OtherBias), data=Quality, method="REML")
summary(model55)
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(OtherBias), data=Quality, method="REML")
summary(model56)
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model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(OtherBias), data=Quality, method="REML")
summary(model57)
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(OtherBias), data=Quality, method="REML")
summary(model58)
#to get the k for each variable
table(tmdwc$RanSeq)
table(tmdhdl$RanSeq)
table(tmdtg$RanSeq)
table(tmdfbg$RanSeq)
table(tmdsbp$RanSeq)
table(tmddbp$RanSeq)
table(tmdwc$AllCon)
table(tmdhdl$AllCon)
table(tmdtg$AllCon)
table(tmdfbg$AllCon)
table(tmdsbp$AllCon)
table(tmddbp$AllCon)
table(tmdwc$Blinding)
table(tmdhdl$Blinding)
table(tmdtg$Blinding)
table(tmdfbg$Blinding)
table(tmdsbp$Blinding)
table(tmddbp$Blinding)
table(tmdwc$Incomp)
table(tmdhdl$Incomp)
table(tmdtg$Incomp)
table(tmdfbg$Incomp)
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table(tmdsbp$Incomp)
table(tmddbp$Incomp)
table(tmdwc$Select)
table(tmdhdl$Select)
table(tmdtg$Select)
table(tmdfbg$Select)
table(tmdsbp$Select)
table(tmddbp$Select)
table(tmdwc$OtherBias)
table(tmdhdl$OtherBias)
table(tmdtg$OtherBias)
table(tmdfbg$OtherBias)
table(tmdsbp$OtherBias)
table(tmddbp$OtherBias)
Moderation with Weeks and Metaregression Plot
model21<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=Weeks,
data=Final, method="REML", slab= paste(Reference, Year, sep =","))
model21pred <- predict(model21, newmods=cbind(seq(0,208,.1)))
wi = Final$w_d.ex.
min= min(wi,na.rm=TRUE)
max= max(wi,na.rm=TRUE)
size= 1.0 + 6.0 * (wi - min)/(max - min)
dietout1= subset(Final,Diet==1 & Out==1) #Here we have to create the
subsample we are working on to just plot the observed values of that below
plot(dietout1$Weeks,dietout1$d.ex.,pch= 20, col="black", bg = "black", cex=size,
xlab = "Number of Weeks", #Plotting here the observed values of the subsample
ylab = "Waist Circumference Effect Size (d)", xlim=c(0, 208), ylim=c(-3, 0.5))
lines(seq(0,208,.1), model21pred$pred, col = "dark red")
#Plotting here the regression line and confidence interval of the predictive model
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lines(seq(0,208,.1), model21pred$ci.lb, lty = "dashed", col="dark red")
lines(seq(0,208,.1), model21pred$ci.ub, lty = "dashed", col="dark red")
model21<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods = Weeks,
data=Final, method="REML", slab= paste(Reference, Year, sep =","))
model21pred <- predict(model21, newmods=cbind(seq(0,208,.1)))
model21

model61<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=Weeks,
data=Final, method="REML", slab= paste(Reference, Year, sep =","))
model61pred <- predict(model61, newmods=cbind(seq(0,208,.1)))
wi = Final$w_d.ex.
min= min(wi, na.rm=TRUE)
max= max(wi, na.rm=TRUE)
size= 1.0 + 6.0 * (wi - min)/(max - min)
dietout1= subset(Final,Diet==1 & Out==3) #Here we have to create the
subsample we are working on to just plot the observed values of that below
plot(dietout1$Weeks,dietout1$d.ex.,pch= 20, col="black", bg = "black", cex=size,
xlab = "Number of Weeks", #Plotting here the observed values of the subsample
ylab = "HDL Effect Size (d)",xlim=c(0, 208), ylim=c(-1.5, 1.5))
lines(seq(0,208,.1), model61pred$pred, col = "dark red")
#Plotting here the regression line and confidence interval of the predictive model
lines(seq(0,208,.1), model61pred$ci.lb, lty = "dashed", col="dark red")
lines(seq(0,208,.1), model61pred$ci.ub, lty = "dashed", col="dark red")
model61

model81<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=Weeks,
data=Final, method="REML", slab= paste(Reference, Year, sep =","))
model81pred <- predict(model81, newmods=cbind(seq(0,208,.1)))
wi = Final$w_d.ex.
min= min(wi, na.rm=TRUE)
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max= max(wi, na.rm=TRUE)
size= 1.0 + 6.0 * (wi - min)/(max - min)
dietout1= subset(Final,Diet==1 & Out==4) #Here we have to create the
subsample we are working on to just plot the observed values of that below
plot(dietout1$Weeks,dietout1$d.ex.,pch= 20, col="black", bg = "black", cex=size,
xlab = "Number of Weeks", #Plotting here the observed values of the subsample
ylab = "Triglycerides Effect Size (d)",xlim=c(0, 208), ylim=c(-3, 0.5))
lines(seq(0,208,.1), model81pred$pred, col = "dark red")
#Plotting here the regression line and confidence interval of the predictive model
lines(seq(0,208,.1), model81pred$ci.lb, lty = "dashed", col="dark red")
lines(seq(0,208,.1), model81pred$ci.ub, lty = "dashed", col="dark red")
model81

model101<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=Weeks,
data=Final, method="REML", slab= paste(Reference, Year, sep =","))
model101pred <- predict(model101, newmods=cbind(seq(0,208,.1)))
wi = Final$w_d.ex.
min= min(wi, na.rm=TRUE)
max= max(wi, na.rm=TRUE)
size= 1.0 + 6.0 * (wi - min)/(max - min)
dietout1= subset(Final,Diet==1 & Out==5) #Here we have to create the
subsample we are working on to just plot the observed values of that below
plot(dietout1$Weeks,dietout1$d.ex.,pch= 20, col="black", bg = "black", cex=size,
xlab = "Number of Weeks", #Plotting here the observed values of the subsample
ylab = "Glucose Effect Size (d)",xlim=c(0, 208), ylim=c(-3, 0.5))
lines(seq(0,208,.1), model101pred$pred, col = "dark red")
#Plotting here the regression line and confidence interval of the predictive model
lines(seq(0,208,.1), model101pred$ci.lb, lty = "dashed", col="dark red")
lines(seq(0,208,.1), model101pred$ci.ub, lty = "dashed", col="dark red")
model101
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model121<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=Weeks,
data=Final, method="REML", slab= paste(Reference, Year, sep =","))
model121pred <- predict(model121, newmods=cbind(seq(0,208,.1)))
wi = Final$w_d.ex.
min= min(wi, na.rm=TRUE)
max= max(wi, na.rm=TRUE)
size= 1.0 + 6.0 * (wi - min)/(max - min)
dietout1= subset(Final,Diet==1 & Out==6) #Here we have to create the
subsample we are working on to just plot the observed values of that below
plot(dietout1$Weeks,dietout1$d.ex.,pch= 20, col="black", bg = "black", cex=size,
xlab = "Number of Weeks", #Plotting here the observed values of the subsample
ylab = "Systolic Blood Pressure Effect Size (d)",xlim=c(0, 208), ylim=c(-3,
0.5))
lines(seq(0,208,.1), model121pred$pred, col = "dark red")
#Plotting here the regression line and confidence interval of the predictive model
lines(seq(0,208,.1), model121pred$ci.lb, lty = "dashed", col="dark red")
lines(seq(0,208,.1), model121pred$ci.ub, lty = "dashed", col="dark red")
model121
model141<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=Weeks,
data=Final, method="REML", slab= paste(Reference, Year, sep =","))
model141pred <- predict(model141, newmods=cbind(seq(0,208,.1)))
wi = Final$w_d.ex.
min= min(wi, na.rm=TRUE)
max= max(wi, na.rm=TRUE)
size= 1.0 + 6.0 * (wi - min)/(max - min)
dietout1= subset(Final,Diet==1 & Out==7) #Here we have to create the
subsample we are working on to just plot the observed values of that below
plot(dietout1$Weeks,dietout1$d.ex.,pch= 20, col="black", bg = "black", cex=size,
xlab = "Number of Weeks", #Plotting here the observed values of the subsample
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ylab = "Diastolic Blood Pressure Effect Size (d)",xlim=c(0, 208), ylim=c(-3,
0.5))
lines(seq(0,208,.1), model141pred$pred, col = "dark red")
#Plotting here the regression line and confidence interval of the predictive model
lines(seq(0,208,.1), model141pred$ci.lb, lty = "dashed", col="dark red")
lines(seq(0,208,.1), model141pred$ci.ub, lty = "dashed", col="dark red")
model141
Moderation for diseasein1_no
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=(diseasein1_no), data=Final, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=(diseasein1_no), data=Final, method="REML")
summary(model554)
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=(diseasein1_no), data=Final, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=(diseasein1_no), data=Final, method="REML")
summary(model556)
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=(diseasein1_no), data=Final, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=(diseasein1_no), data=Final, method="REML")
summary(model558)
Moderation for Year
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=Year,
data=Final, method="REML")
summary(model6651)
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=Year,
data=Final, method="REML")
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summary(model6653)
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=Year,
data=Final, method="REML")
summary(model6654)
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=Year,
data=Final, method="REML")
summary(model6655)
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=Year,
data=Final, method="REML")
summary(model6656)
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=Year,
data=Final, method="REML")
summary(model6657)
Moderation for Score
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=score,
data=Final, method="REML")
summary(model6651)
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=score,
data=Final, method="REML")
summary(model6653)
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=score,
data=Final, method="REML")
summary(model6654)
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=score,
data=Final, method="REML")
summary(model6655)
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=score,
data=Final, method="REML")
summary(model6656)
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=score,
data=Final, method="REML")
summary(model6657)
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Moderation for No_FEMin1
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=No_FEMin1, data=MetRisk, method="REML")
summary(model6651)
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=No_FEMin1, data=MetRisk, method="REML")
summary(model6653)
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=No_FEMin1, data=MetRisk, method="REML")
summary(model6654)
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=No_FEMin1, data=MetRisk, method="REML")
summary(model6655)
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=No_FEMin1, data=MetRisk, method="REML")
summary(model6656)
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=No_FEMin1, data=MetRisk, method="REML")
summary(model6657)
Moderation for Prop_FEMin1
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=Prop_FEMin1, data=MetRisk, method="REML")
summary(model6651)
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=Prop_FEMin1, data=MetRisk, method="REML")
summary(model6653)
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=Prop_FEMin1, data=MetRisk, method="REML")
summary(model6654)
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=Prop_FEMin1, data=MetRisk, method="REML")
summary(model6655)
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model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=Prop_FEMin1, data=MetRisk, method="REML")
summary(model6656)
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=Prop_FEMin1, data=MetRisk, method="REML")
summary(model6657)
Moderation for n_in1
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=n_in1,
data=Final, method="REML")
summary(model6651)
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=n_in1,
data=Final, method="REML")
summary(model6653)
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=n_in1,
data=Final, method="REML")
summary(model6654)
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=n_in1,
data=Final, method="REML")
summary(model6655)
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=n_in1,
data=Final, method="REML")
summary(model6656)
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=n_in1,
data=Final, method="REML")
summary(model6657)
Moderation for n_total
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=n_total,
data=MetRisk, method="REML")
summary(model6651)
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=n_total,
data=MetRisk, method="REML")
summary(model6653)
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model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=n_total,
data=MetRisk, method="REML")
summary(model6654)
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=n_total,
data=MetRisk, method="REML")
summary(model6655)
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=n_total,
data=MetRisk, method="REML")
summary(model6656)
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=n_total,
data=MetRisk, method="REML")
summary(model6657)
Moderation for agein1
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=agein1,
data=Final, method="REML")
summary(model6651)
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=agein1,
data=Final, method="REML")
summary(model6653)
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=agein1,
data=Final, method="REML")
summary(model6654)
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=agein1,
data=Final, method="REML")
summary(model6655)
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=agein1,
data=Final, method="REML")
summary(model6656)
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=agein1,
data=Final, method="REML")
summary(model6657)
Moderation for disease_in1 prop
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model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=diseasein1_prop, data=Final, method="REML")
summary(model6651)
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=diseasein1_prop, data=Final, method="REML")
summary(model6653)
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=diseasein1_prop, data=Final, method="REML")
summary(model6654)
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=diseasein1_prop, data=Final, method="REML")
summary(model6655)
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=diseasein1_prop, data=Final, method="REML")
summary(model6656)
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=diseasein1_prop, data=Final, method="REML")
summary(model6657)
Moderation for diseasein1_no
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=diseasein1_no, data=Final, method="REML")
summary(model6651)
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=diseasein1_no, data=Final, method="REML")
summary(model6653)
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=diseasein1_no, data=Final, method="REML")
summary(model6654)
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=diseasein1_no, data=Final, method="REML")
summary(model6655)
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model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=diseasein1_no, data=Final, method="REML")
summary(model6656)
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=diseasein1_no, data=Final, method="REML")
summary(model6657)
Moderation for medin1_prop
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=medin1_prop, data=MetRisk, method="REML")
summary(model6651)
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=medin1_prop, data=MetRisk, method="REML")
summary(model6653)
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=medin1_prop, data=MetRisk, method="REML")
summary(model6654)
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=medin1_prop, data=MetRisk, method="REML")
summary(model6655)
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=medin1_prop, data=MetRisk, method="REML")
summary(model6656)
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=medin1_prop, data=MetRisk, method="REML")
summary(model6657)
Moderation for medin1_no
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=medin1_no,
data=MetRisk, method="REML")
summary(model6651)
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=medin1_no,
data=MetRisk, method="REML")
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summary(model6653)
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=medin1_no,
data=MetRisk, method="REML")
summary(model6654)
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=medin1_no,
data=MetRisk, method="REML")
summary(model6655)
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=medin1_no,
data=MetRisk, method="REML")
summary(model6656)
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=medin1_no,
data=MetRisk, method="REML")
summary(model6657)
Moderation for kcaltot_in1
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=kcaltot_in1,
data=MetRisk, method="REML")
summary(model6651)
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=kcaltot_in1,
data=MetRisk, method="REML")
summary(model6653)
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=kcaltot_in1,
data=MetRisk, method="REML")
summary(model6654)
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=kcaltot_in1,
data=MetRisk, method="REML")
summary(model6655)
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=kcaltot_in1,
data=MetRisk, method="REML")
summary(model6656)
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=kcaltot_in1,
data=MetRisk, method="REML")
summary(model6657)
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Prop CHO
model6651<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=propcho_in1, data=Final, method="REML")
summary(model6651)
model6653<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=propcho_in1, data=Final, method="REML")
summary(model6653)
model6654<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=propcho_in1, data=Final, method="REML")
summary(model6654)
model6655<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=propcho_in1, data=Final, method="REML")
summary(model6655)
model6656<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=propcho_in1, data=Final, method="REML")
summary(model6656)
model6657<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=propcho_in1, data=Final, method="REML")
summary(model6657)
Moderator for Region 1 and Region 4
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 &
(region==1|region==4)), mods=~factor(region), data=Final, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3 &
(region==1|region==4)), mods=~factor(region), data=Final, method="REML")
summary(model554)
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4 &
(region==1|region==4)), mods=~factor(region), data=Final, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5 &
(region==1|region==4)), mods=~factor(region), data=Final, method="REML")
summary(model556)
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model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6 &
(region==1|region==4)), mods=~factor(region), data=Final, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7 &
(region==1|region==4)), mods=~factor(region), data=Final, method="REML")
summary(model558)
Moderation for disease_in1
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=~factor(disease_in1), data=Final, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(disease_in1), data=Final, method="REML")
summary(model554)
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(disease_in1), data=Final, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(disease_in1), data=Final, method="REML")
summary(model556)
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(disease_in1), data=Final, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(disease_in1), data=Final, method="REML")
summary(model558)
Moderation for Supple_in1
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=~factor(Supple_in1), data=Final, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(Supple_in1), data=Final, method="REML")
summary(model554)
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model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(Supple_in1), data=Final, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(Supple_in1), data=Final, method="REML")
summary(model556)
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(Supple_in1), data=Final, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(Supple_in1), data=Final, method="REML")
summary(model558)
Moderation for alcohol_in1
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=~factor(alcohol_in1), data=Final, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(alcohol_in1), data=Final, method="REML")
summary(model554)
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(alcohol_in1), data=Final, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(alcohol_in1), data=Final, method="REML")
summary(model556)
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(alcohol_in1), data=Final, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(alcohol_in1), data=Final, method="REML")
summary(model558)
Moderation for oc_in1
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model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=~factor(oc_in1), data=Final, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(oc_in1), data=Final, method="REML")
summary(model554)
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(oc_in1), data=Final, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(oc_in1), data=Final, method="REML")
summary(model556)
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(oc_in1), data=Final, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(oc_in1), data=Final, method="REML")
summary(model558)
Moderation for smoke_in1
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=~factor(smoke_in1), data=Final, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(smoke_in1), data=Final, method="REML")
summary(model554)
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(smoke_in1), data=Final, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(smoke_in1), data=Final, method="REML")
summary(model556)
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model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(smoke_in1), data=Final, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(smoke_in1), data=Final, method="REML")
summary(model558)
Moderation for congrp
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=~factor(congrp), data=Final, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(congrp), data=Final, method="REML")
summary(model554)
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(congrp), data=Final, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(congrp), data=Final, method="REML")
summary(model556)
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(congrp), data=Final, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(congrp), data=Final, method="REML")
summary(model558)
Moderation for provision_in1
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=~factor(provision_in1), data=Final, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(provision_in1), data=Final, method="REML")
summary(model554)
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model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(provision_in1), data=Final, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(provision_in1), data=Final, method="REML")
summary(model556)
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(provision_in1), data=Final, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(provision_in1), data=Final, method="REML")
summary(model558)
Moderation for macrodist_in1
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=~factor(macrodist_in1), data=Final, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(macrodist_in1), data=Final, method="REML")
summary(model554)
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(macrodist_in1), data=Final, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(macrodist_in1), data=Final, method="REML")
summary(model556)
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(macrodist_in1), data=Final, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(macrodist_in1), data=Final, method="REML")
summary(model558)
Moderation for propcho_in1
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model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=~factor(propcho_in1), data=Final, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(propcho_in1), data=Final, method="REML")
summary(model554)
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(propcho_in1), data=Final, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(propcho_in1), data=Final, method="REML")
summary(model556)
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(propcho_in1), data=Final, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(propcho_in1), data=Final, method="REML")
summary(model558)
Moderation for prop_satfatin1
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=~factor(propsatfat_in1), data=Final, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(propsatfat_in1), data=Final, method="REML")
summary(model554)
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(propsatfat_in1), data=Final, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(propsatfat_in1), data=Final, method="REML")
summary(model556)
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model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(propsatfat_in1), data=Final, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(propsatfat_in1), data=Final, method="REML")
summary(model558)
Moderation for proptotfat_in1
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=~factor(proptotfat_in1), data=Final, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(proptotfat_in1), data=Final, method="REML")
summary(model554)
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(proptotfat_in1), data=Final, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(proptotfat_in1), data=Final, method="REML")
summary(model556)
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(proptotfat_in1), data=Final, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(proptotfat_in1), data=Final, method="REML")
summary(model558)
Moderation for proppro_in 1
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=~factor(proppro_in1), data=Final, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(proppro_in1), data=Final, method="REML")
summary(model554)
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model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(proppro_in1), data=Final, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(proppro_in1), data=Final, method="REML")
summary(model556)
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(proppro_in1), data=Final, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(proppro_in1), data=Final, method="REML")
summary(model558)
Moderation for lang
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=~factor(lang)-1,
data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=~factor(lang)-1,
data=MetRisk, method="REML")
model994
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=~factor(lang)-1,
data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=~factor(lang)-1,
data=MetRisk, method="REML")
model996
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=~factor(lang)-1,
data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=~factor(lang)-1,
data=MetRisk, method="REML")
model998
Moderation for pop
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model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=~factor(pop)1, data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=~factor(pop)1, data=MetRisk, method="REML")
model994
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=~factor(pop)1, data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=~factor(pop)1, data=MetRisk, method="REML")
model996
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=~factor(pop)1, data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=~factor(pop)1, data=MetRisk, method="REML")
model998
Moderation for diet_in1
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(diet_in1), data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(diet_in1), data=MetRisk, method="REML")
model994
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(diet_in1), data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(diet_in1), data=MetRisk, method="REML")
model996
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model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(diet_in1), data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(diet_in1), data=MetRisk, method="REML")
model998
Moderation for Interlvl
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=~factor(interlvl), data=Final, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(interlvl), data=Final, method="REML")
summary(model554)
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(interlvl), data=Final, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(interlvl), data=Final, method="REML")
summary(model556)
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(interlvl), data=Final, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(interlvl), data=Final, method="REML")
summary(model558)
Moderation for Region-1
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=~factor(region)-1,
data=Final, method="REML")
model53
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=~factor(region)-1,
data=Final, method="REML")
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model54
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=~factor(region)-1,
data=Final, method="REML")
model55
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=~factor(region)-1,
data=Final, method="REML")
model56
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=~factor(region)-1,
data=Final, method="REML")
model57
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=~factor(region)-1,
data=Final, method="REML")
model58

Tables for k of each Region
table(tmdwc$region)
table(tmdhdl$region)
table(tmdtg$region)
table(tmdfbg$region)
table(tmdsbp$region)
table(tmddbp$region)
Moderation for congrp-1
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(congrp)-1, data=Final, method="REML")
model53
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(congrp)-1, data=Final, method="REML")
model54
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(congrp)-1, data=Final, method="REML")
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model55
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(congrp)-1, data=Final, method="REML")
model56
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(congrp)-1, data=Final, method="REML")
model57
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(congrp)-1, data=Final, method="REML")
model58
Tables for k of each congrp
table(tmdwc$congrp)
table(tmdhdl$congrp)
table(tmdtg$congrp)
table(tmdfbg$congrp)
table(tmdsbp$congrp)
table(tmddbp$congrp)
Moderation for medin1-1
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(medin1)-1, data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(medin1)-1, data=MetRisk, method="REML")
model994
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(medin1)-1, data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(medin1)-1, data=MetRisk, method="REML")
model996
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model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(medin1)-1, data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(medin1)-1, data=MetRisk, method="REML")
model998
Moderation for experiment-1
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(experiment)-1, data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(experiment)-1, data=MetRisk, method="REML")
model994
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(experiment)-1, data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(experiment)-1, data=MetRisk, method="REML")
model996
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(experiment)-1, data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(experiment)-1, data=MetRisk, method="REML")
model998
Moderation for diet_monitor-1
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(diet_monitor)-1, data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(diet_monitor)-1, data=MetRisk, method="REML")
model994
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model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(diet_monitor)-1, data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(diet_monitor)-1, data=MetRisk, method="REML")
model996
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(diet_monitor)-1, data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(diet_monitor)-1, data=MetRisk, method="REML")
model998
Moderation for behave-1
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(behave)-1, data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(behave)-1, data=MetRisk, method="REML")
model994
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(behave)-1, data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(behave)-1, data=MetRisk, method="REML")
model996
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(behave)-1, data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(behave)-1, data=MetRisk, method="REML")
model998
Moderation for compliance_in1-1
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model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(compliance_in1)-1, data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(compliance_in1)-1, data=MetRisk, method="REML")
model994
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(compliance_in1)-1, data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(compliance_in1)-1, data=MetRisk, method="REML")
model996
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(compliance_in1)-1, data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(compliance_in1)-1, data=MetRisk, method="REML")
model998
Moderation for measure_ad_in1-1
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(measure_ad_in1)-1, data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(measure_ad_in1)-1, data=MetRisk, method="REML")
model994
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(measure_ad_in1)-1, data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(measure_ad_in1)-1, data=MetRisk, method="REML")
model996
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model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(measure_ad_in1)-1, data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(measure_ad_in1)-1, data=MetRisk, method="REML")
model998
Moderation for scale_in1-1
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(scale_in1)-1, data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(scale_in1)-1, data=MetRisk, method="REML")
model994
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(scale_in1)-1, data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(scale_in1)-1, data=MetRisk, method="REML")
model996
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(scale_in1)-1, data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(scale_in1)-1, data=MetRisk, method="REML")
model998
Moderation for counsel_in1-1
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(counsel_in1)-1, data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(counsel_in1)-1, data=MetRisk, method="REML")
model994
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model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(counsel_in1)-1, data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(counsel_in1)-1, data=MetRisk, method="REML")
model996
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(counsel_in1)-1, data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(counsel_in1)-1, data=MetRisk, method="REML")
model998
Moderation for QoL_in1-1
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(QoL_in1)-1, data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(QoL_in1)-1, data=MetRisk, method="REML")
model994
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(QoL_in1)-1, data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(QoL_in1)-1, data=MetRisk, method="REML")
model996
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(QoL_in1)-1, data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(QoL_in1)-1, data=MetRisk, method="REML")
model998
Moderation for cho_in1-1
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model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(cho_in1)-1, data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(cho_in1)-1, data=MetRisk, method="REML")
model994
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(cho_in1)-1, data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(cho_in1)-1, data=MetRisk, method="REML")
model996
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(cho_in1)-1, data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(cho_in1)-1, data=MetRisk, method="REML")
model998
Moderation for satfat_in1-1
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(satfat_in1)-1, data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(satfat_in1)-1, data=MetRisk, method="REML")
model994
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(satfat_in1)-1, data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(satfat_in1)-1, data=MetRisk, method="REML")
model996
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model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(satfat_in1)-1, data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(satfat_in1)-1, data=MetRisk, method="REML")
model998
Moderation for totfat_in1-1
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(totfat_in1)-1, data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(totfat_in1)-1, data=MetRisk, method="REML")
model994
model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(totfat_in1)-1, data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(totfat_in1)-1, data=MetRisk, method="REML")
model996
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(totfat_in1)-1, data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(totfat_in1)-1, data=MetRisk, method="REML")
model998
Moderation for pro_in1-1
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(pro_in1)-1, data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(pro_in1)-1, data=MetRisk, method="REML")
model994
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model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(pro_in1)-1, data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(pro_in1)-1, data=MetRisk, method="REML")
model996
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(pro_in1)-1, data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(pro_in1)-1, data=MetRisk, method="REML")
model998
Moderation for CVD-1
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=~factor(CVD)-1, data=MetRisk, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(CVD)-1, data=MetRisk, method="REML")
summary(model554)
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(CVD)-1, data=MetRisk, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(CVD)-1, data=MetRisk, method="REML")
summary(model556)
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(CVD)-1, data=MetRisk, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(CVD)-1, data=MetRisk, method="REML")
summary(model558)
Moderation for DM-1
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model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ), mods=~factor(DM)1, data=MetRisk, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=~factor(DM)1, data=MetRisk, method="REML")
summary(model554)
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=~factor(DM)1, data=MetRisk, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=~factor(DM)1, data=MetRisk, method="REML")
summary(model556)
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=~factor(DM)1, data=MetRisk, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=~factor(DM)1, data=MetRisk, method="REML")
summary(model558)
Moderation for MetS-1
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=~factor(MetS)-1, data=MetRisk, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(MetS)-1, data=MetRisk, method="REML")
summary(model554)
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(MetS)-1, data=MetRisk, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(MetS)-1, data=MetRisk, method="REML")
summary(model556)
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model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(MetS)-1, data=MetRisk, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(MetS)-1, data=MetRisk, method="REML")
summary(model558)
Moderation for overwtobes-1
model553<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1 ),
mods=~factor(overwtobes)-1, data=MetRisk, method="REML")
summary(model553)
model554<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(overwtobes)-1, data=MetRisk, method="REML")
summary(model554)
model555<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(overwtobes)-1, data=MetRisk, method="REML")
summary(model555)
model556<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(overwtobes)-1, data=MetRisk, method="REML")
summary(model556)
model557<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(overwtobes)-1, data=MetRisk, method="REML")
summary(model557)
model558<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(overwtobes)-1, data=MetRisk, method="REML")
summary(model558)
Moderation for interlvl-1
model993<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1),
mods=~factor(interlvl)-1, data=MetRisk, method="REML")
model993
model994<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3),
mods=~factor(interlvl)-1, data=MetRisk, method="REML")
model994
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model995<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4),
mods=~factor(interlvl)-1, data=MetRisk, method="REML")
model995
model996<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5),
mods=~factor(interlvl)-1, data=MetRisk, method="REML")
model996
model997<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6),
mods=~factor(interlvl)-1, data=MetRisk, method="REML")
model997
model998<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7),
mods=~factor(interlvl)-1, data=MetRisk, method="REML")
model998
Region-1
model53<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=~factor(region)-1,
data=Final, method="REML")
model53
model54<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==3), mods=~factor(region)-1,
data=Final, method="REML")
model54
model55<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==4), mods=~factor(region)-1,
data=Final, method="REML")
model55
model56<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==5), mods=~factor(region)-1,
data=Final, method="REML")
model56
model57<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==6), mods=~factor(region)-1,
data=Final, method="REML")
model57
model58<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==7), mods=~factor(region)-1,
data=Final, method="REML")
model58
Tables for k of each region
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table(tmdwc$region)
table(tmdhdl$region)
table(tmdtg$region)
table(tmdfbg$region)
table(tmdsbp$region)
table(tmddbp$region)
Moving the constant For Min Weeks and Max Weeks
maxweeks=208-Final$Weeks
maxweeks
minweeks=Final$Weeks-4
minweeks
model23<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=maxweeks, data=Final, method=
"REML", slab= paste(Reference, Year, sep =","))
model23
model25<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=minweeks, data=Final, method=
"REML", slab= paste(Reference, Year, sep =","))
model25
model63<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), mods=maxweeks, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model63
model65<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), mods=minweeks, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model65
model83<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), mods=maxweeks, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model83
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model85<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), mods=minweeks, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model85
model103<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), mods=maxweeks, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model103
model105<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), mods=minweeks, data=Final, method=
"REML",slab= paste(Reference, Year, sep=""))
model105
model123<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), mods=maxweeks, data=Final, method=
"REML",slab= paste(Reference, Year, sep=""))
model123
model125<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), mods=minweeks, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model125
model143<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), mods=maxweeks, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model143
model145<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), mods=minweeks, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model145
Max and Min Total Sample Size
maxtot=1154-Final$n_tot
maxtot
mintot=Final$n_tot-12
mintot
model107<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==1), mods=mintot, data=Final, method=
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"REML", slab= paste(Reference, Year, sep=""))
model107
model87<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==1), mods=maxtot, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model87
model107<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), mods=mintot, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model107
model87<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), mods=maxtot, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model87
model107<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), mods=mintot, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model107
model87<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), mods=maxtot, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model87
model106<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), mods=mintot, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model106
model107<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), mods=maxtot, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model107
model126<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), mods=mintot, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model126
model127<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), mods=maxtot, data=Final, method=
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"REML", slab= paste(Reference, Year, sep=""))
model127
model146<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), mods=mintot, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model146
model147<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), mods=maxtot, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model147
Min and Max in Intervention 1
maxsamp=1154-Final$n_in1
maxsamp
minsamp=Final$n_in1-11
minsamp
model27<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=minsamp, data=Final, method=
"REML", slab= paste(Reference, Year, sep =","))
model27
model26<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=maxsamp, data=Final, method=
"REML", slab= paste(Reference, Year, sep =","))
model26
model66<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), mods=minsamp, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model66
model67<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), mods=maxsamp, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model67
model86<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), mods=minsamp, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
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model86
model87<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), mods=maxsamp, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model87
model106<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), mods=minsamp, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model106
model107<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), mods=maxsamp, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model107
model126<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), mods=minsamp, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model126
model127<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), mods=maxsamp, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model127
model146<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), mods=minsamp, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model146
model147<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), mods=maxsamp, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model147
Min and Max Age for Intervention
maxage=65-Final$agein1
maxage
minage=Final$agein1-8.8
minage
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model27<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=minage, data=Final, method=
"REML", slab= paste(Reference, Year, sep =","))
model27
model26<-rma(d.ex.,var_d.ex.,subset=(Diet==1 & Out==1), mods=maxage, data=Final, method=
"REML", slab= paste(Reference, Year, sep =","))
model26
model66<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), mods=minage, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model66
model67<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==3), mods=maxage, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model67
model86<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), mods=minage, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model86
model87<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==4), mods=maxage, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model87
model106<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), mods=minage, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model106
model107<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==5), mods=maxage, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model107
model126<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), mods=minage, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model126
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model127<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==6), mods=maxage, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model127
model146<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), mods=minage, data=Final, method=
"REML",slab= paste(Reference, Year, sep=""))
model146
model147<-rma(d.ex.,var_d.ex.,subset=(Diet==1&Out==7), mods=maxage, data=Final, method=
"REML", slab= paste(Reference, Year, sep=""))
model147
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